Skip to main content
Cold Spring Harbor Perspectives in Biology logoLink to Cold Spring Harbor Perspectives in Biology
. 2016 Feb;8(2):a020453. doi: 10.1101/cshperspect.a020453

Oligodendrocyte Development and Plasticity

Dwight E Bergles 1, William D Richardson 2
PMCID: PMC4743079  PMID: 26492571

Abstract

Oligodendrocyte precursor cells (OPCs) originate in the ventricular zones (VZs) of the brain and spinal cord and migrate throughout the developing central nervous system (CNS) before differentiating into myelinating oligodendrocytes (OLs). It is not known whether OPCs or OLs from different parts of the VZ are functionally distinct. OPCs persist in the postnatal CNS, where they continue to divide and generate myelinating OLs at a decreasing rate throughout adult life in rodents. Adult OPCs respond to injury or disease by accelerating their cell cycle and increasing production of OLs to replace lost myelin. They also form synapses with unmyelinated axons and respond to electrical activity in those axons by generating more OLs and myelin locally. This experience-dependent “adaptive” myelination is important in some forms of plasticity and learning, for example, motor learning. We review the control of OL lineage development, including OL population dynamics and adaptive myelination in the adult CNS.


Unlike most progenitors, oligodendrocyte precursor cells remain abundant in the adult central nervous system. They are crucial for healthy brain function, as well as for myelin repair in demyelinating diseases (e.g., multiple sclerosis).


Oligodendrocytes (OLs), the myelin-forming cells of the central nervous system (CNS), develop from glial progenitor cells, known as “oligodendrocyte precursor cells” (OPCs), which arise from several parts of the ventricular germinal zones of the embryonic neural tube. OPCs proliferate and migrate away from these zones into developing gray and white matter before differentiating into myelin-forming OLs. However, unlike most progenitors, OPCs remain abundant in the adult CNS, where they retain the ability to generate new OLs that allow rapid regeneration of myelin that might be lost through normal aging or disease, as well as changing the pattern of myelination in response to life experience. These cells have been under intense scrutiny since their first discovery (Raff et al. 1983) because it was soon recognized that understanding the cell and developmental biology of OPCs would be key to understanding how to control myelin production and regeneration in CNS diseases and injuries in which myelin destruction is a major cause of pathology and disability. OPCs have also been referred to as “NG2 cells” (because they express the NG2 proteoglycan on their surface) or “polydendrocytes” (because they have multiple processes); for simplicity, we refer to them as OPCs. Here, we provide an overview of the mechanisms that specify OPC generation, their physiological properties, and the pathways that influence their behavior during development. We also consider their role in the adult CNS, with a focus on myelin plasticity.

VENTRAL AND DORSAL ORIGINS of OLs IN MAMMALIAN SPINAL CORD

OPCs can be identified in fixed CNS tissue by immunohistochemistry and/or in situ hybridization for NG2 or the platelet-derived growth factor receptor (α-subunit, Pdgfra), together with the transcription factors Olig2 and Sox10. NG2 and Pdgfra are down-regulated rapidly when OPCs start to differentiate into OLs, but Sox10 and Olig2 continue to be expressed in mature OLs. OPCs can first be detected in the ventricular germinal zones (VZs) of the brain and spinal cord around midgestation in rodents. In transverse sections of cervical spinal cord small clusters of (Olig2+, Sox10+, Pdgfra+), OPCs appear in the ventral VZ near the floor plate around embryonic day 12.5 (E12.5) in mice, E14 in rats, E6–E7 in chicks, or gestational week 6.5 (∼E45) in humans (Fig. 1A–D) (Pringle and Richardson 1993; Timsit et al. 1995; Hajihosseini et al. 1996; Orentas and Miller 1996). They presumably arise by division of radial stem cells (radial glia) in the VZ, one of the daughters retaining contact with the ventricular and pial surfaces and the other daughter (the OPC) losing those contacts, in much the same way that migratory neuronal progenitors are generated, although time-lapse imaging has not been performed to confirm this sequence of events. Soon after they appear, these ventrally derived OPCs proliferate rapidly and migrate in all directions, becoming evenly distributed through the cord in both gray and white matter by ∼E15 in mice (Pringle and Richardson 1993).

Figure 1.

Figure 1.

Specification and proliferation of OPCs in the developing spinal cord. (A) Neural stem cells in the pMN domain of the embryonic spinal cord near the floor plate express Olig2 (magenta) and make MNs (marked by expression of transcription factor HB9) from ∼E9–E12 in mouse. (B) Starting on ∼E12.5, the pMN stem cells switch to making OPCs, which express Pdgfra (red). The Nkx2.2+ nuclei outside the VZ are mostly interneurons. Pdgfra+ OPCs start to express Nkx2.2 as they migrate away from the midline and up-regulate its expression as they differentiate into OLs. (Images A and B provided by Dr. Raquel Taveira-Marques.) (C) Pdgfra+ OPCs migrate throughout the developing cord and become evenly distributed in future gray and white matter before birth on ∼E18.5. (D) Specification of OPCs in the ventral human spinal cord follows a similar pattern as mouse; Olig2+ (green) neural stem cells in the pMN domain generate migratory OPCs. Many OPCs at the edges of the VZ coexpress Nkx2.2 (red) in humans. (Image kindly provided by Dr. Pantelis Tsouflas, University of Miami.) (E,F) Starting ∼E16.5 in mouse, some radial glia in the intermediate and dorsal spinal cord start to express OL lineage markers Olig2 and Sox10 (arrows) and transdifferentiate into OPCs. Here, green fluorescent protein (GFP) is expressed under the control of Dbx1, which is expressed in the VZ at the dorsoventral boundary of the cord. (From Fogarty et al. 2005; adapted, with permission, from the investigators). (G) A two-color reporter Sox10-GFP-STOP-tdTom (tandem-duplicated Tomato), when combined with a dorsally expressed Cre transgene Msx3-Cre, labels pMN-derived OPCs/OLs green and dorsally derived OPCs/OLs red. Dorsally derived OL lineage cells are ∼20% of the total and mainly populate dorsal and intermediate axon tracts (Tripathi et al. 2011). (H) OPCs in the gray matter of the wild-type postnatal cord are evenly spaced. (I) In NSE-Pdgf-A transgenic mice (which greatly overproduce Pdgf-A in neurons), OPCs (Pdgfra+) proliferate more than normal and pile up in tumor-like masses (van Heyningen et al. 2001). Pdgf-A overexpression also increases OPC numbers in adulthood (Woodruff et al. 2004). WT, wild type.

The ventral “clusters” of OPCs described above are, in fact, cross-sectional views of narrow columns of cells that run all along the length of the spinal cord into the hindbrain and midbrain. The position of the OPCs, close to but not in contact with the floor plate, corresponds to the “pMN” progenitor domain that, just before OPC production, generates motor neurons (MNs). Speculations on the evolutionary significance of this close developmental relationship between MNs and OLs can be found elsewhere (Richardson et al. 1997; Li and Richardson 2008). The molecular mechanisms that cause MNs and OPCs to be generated sequentially from the same progenitor domain, presumably from a common set of radial stem cells, are discussed below (see section Determinants of OPC Specification and Neuron-OPC Fate Switching).

After the initial production of OPCs from the pMN domain in the ventral spinal cord, a second wave of OPC production begins in the dorsal cord at ∼E15.5 (Cai et al. 2005; Fogarty et al. 2005; Vallstedt et al. 2005; Tripathi et al. 2011). These dorsally derived OPCs transdifferentiate from radial glia as they retract their apical processes from the central canal toward the pial surface (Fig. 1E,F) (Fogarty et al. 2005). Most radial glia transform into white- and gray-matter astrocytes, but a subset starts to express OPC markers Olig2, Sox10, and Pdgfra. Their endfeet remain attached to the pial undersurface during this process, and, presumably because of this, dorsally derived OPCs do not migrate as widely as ventrally derived OPCs, most of them remaining in the dorsal half of the cord where they gradually displace their ventrally derived counterparts from dorsal axon tracts (Tripathi et al. 2011). Dorsally derived OPCs ultimately make up ∼20% of all OPCs in the mouse spinal cord, the remaining ∼80% coming from the pMN domain (Fig. 1G) (Tripathi et al. 2011).

Shortly before birth (∼E18.5 in mice), some OPCs in the spinal cord start to generate differentiated OLs that express myelin genes, including myelin basic protein (MBP) and the myelin proteolipid protein (PLP); these OLs first appear in the ventral and dorsal funiculi (developing white matter) where they associate with axons and start to elaborate myelin. OL production throughout the white and gray matter gathers pace after birth, reaching a maximum ∼2–4 wk postnatal in mice, but continuing for at least 8 postnatal months, although at an ever-decreasing rate (Rivers et al. 2008). The function of the late-born OLs and the myelin they produce is considered later in this review.

VENTRAL VERSUS DORSAL ORIGINS OF OLs IN THE BRAIN

An analogous series of events plays out in the telencephalon (embryonic precursor of the forebrain). OPCs first appear in the ventral VZ of the medial ganglionic eminence ([MGE] territory marked by expression of transcription factor Nkx2.1) ∼E12.5 in mice; soon afterward, they begin to be generated from the lateral ganglionic eminence ([LGE] Gsx2 territory) (Fig. 2A–C) (Kessaris et al. 2006). They migrate laterally and dorsally from the MGE and LGE, many as far as the developing cerebral cortex, which they invade in a lateral-to-medial direction from ∼E16. Soon after birth, another wave of OPC production starts from the cortical VZ (Emx1 territory) (Kessaris et al. 2006). After birth, MGE-derived OPCs are gradually eliminated from the cortex by an unknown mechanism; hence, OPCs in the adult mouse cortex (motor area) are derived mainly from the cortical VZ with an ∼20% contribution from the LGE (Tripathi et al. 2011). It is unclear whether OPCs are produced uniformly from all parts of the cortical VZ or preferentially from some regions, for example, the lateral edges of the cortical VZ (Ivanova et al. 2003; Nakahira et al. 2006) and/or the dorsal aspect of the postnatal subventricular zone (SVZ) (Levison and Goldman 1993; Tsoa et al. 2014).

Figure 2.

Figure 2.

Development of the OL lineage in the forebrain. (A) In situ hybridization reveals that the first Pdgfra+ precursor cells appear in the ventral VZ (MGE) of the rat telencephalon (forerunner of the forebrain) ∼E13.5 (∼E12.5 in mice); some of these are OPCs that migrate through the developing forebrain, reaching the cortex (Cx) after ∼E17 (∼E16 in mice) (Tekki-Kessaris et al. 2001). Note that Pdgfra is expressed in many cells and tissues outside the CNS. (B) Lateral view of the developing rodent brain, indicating the plane of the section and the position of the Pdgfra+ cells in A. (C) After the first OPCs appear in the MGE (Nkx2.1 territory), a second “wave” of OPCs arises in the LGE (Gsx2 territory) and, after birth, a third wave within the cortical VZ (Emx1 territory). Cortically derived OPCs settle within the cortex and comprise ∼80% of all OPCs in the adult cortex (Tripathi et al. 2011). (D) A Sox10-driven green fluorescent protein–diphtheria toxin A chain (GFP–STOP-DTA) reporter illustrates the near-uniform distribution of OPCs in the perinatal mouse forebrain (very few OLs are present in the brain at birth). (D′) When the same Sox10 reporter is combined with three Cre transgenes (3xCre; Emx1-Cre, Gsx2-Cre, Nkx2.1-Cre), diphtheria toxin A chain (DTA) is expressed and kills the developing OPCs. (Images D and D′ from Iannarelli 2014.) Despite the fact that practically all telencephalic OPCs are eliminated at their source, the ventral forebrain is rapidly repopulated by OPCs that migrate forward from the diencephalon. At birth, the cortex is still almost devoid of OPCs, but is repopulated within the first 2 postnatal weeks; the mice survive and reproduce normally, although their body size is slightly reduced. Cx, cortex; MGE, medial ganglionic eminence; LGE, lateral ganglionic eminence; 3 V, third ventricle; CP, choroid plexus; Te, telencephalon; Di, diencephalon.

NONMAMMALIAN VERTEBRATES

Early development of OPCs in the avian spinal cord and brain follows a similar pattern as in rodents. For example, (Sox10+, Pdgfra+) OPCs first appear in the ventral VZ of the chick thoracic spinal cord ∼E6 (Hamilton–Hamburger stage 29) and migrate from there throughout the cord (Ono et al. 1995). In the chick forebrain, OPCs originate in the ventral telencephalon and disperse from there throughout the ventral and dorsal developing forebrain (Olivier et al. 2001). It has also been shown that OPCs, destined for chick optic nerves, originate in the VZ at the ventral midline of the diencephalon underneath the third ventricle (Ono et al. 1997). It is likely that this and perhaps other local “oligogenic” zones exist in mammals too, but have yet to be described. These chick studies emphasize ventral origins of OPCs; it is not clear whether the dorsal sources of OPCs described in the mouse spinal cord and forebrain also exist in birds (Olivier et al. 2001). Attempts to address this question for the spinal cord using chick–quail chimeras led to conflicting conclusions for reasons of methodology and interpretation (discussed in Richardson et al. 2006). However, both ventral and dorsal sources have been shown to exist in the embryonic chick midbrain (Fu et al. 2003) and hindbrain (Davies and Miller 2001).

Although some OL lineage markers are common to all vertebrates, the timing of their appearance can vary among species. In the chick spinal cord, for example, monoclonal antibody O4 labels all OPCs from the time of their first appearance in the ventral VZ until after they differentiate into OLs (Ono et al. 1995), whereas, in rats and mice, O4 is not expressed until the early differentiating (premyelinating) stage after Pdgfra is down-regulated (Hall et al. 1996; Bansal and Pfeiffer 1997). Similarly, antibody A2B5, which has been useful for labeling all OPCs (along with other neural precursors) in rats (Raff et al. 1983; Baracskay et al. 2007), labels only a subset of OPCs in mice (Fanarraga et al. 1995). Moreover, zebrafish OPCs appear to lack Pdgfra expression (Park et al. 2002; Mora 2005). These observations illustrate the obvious point that care is needed when generalizing across species—even among different mammals. The remainder of this review deals with mouse development, unless stated otherwise.

DETERMINANTS OF OPC SPECIFICATION AND NEURON–OPC FATE SWITCHING

Development of the ventral spinal cord is directed by diffusible signals, including Sonic hedgehog (Shh) from the notochord and floor plate at the ventral midline, modulated by bone morphogenetic proteins (Bmps) and Wnts from the roof plate at the dorsal midline. This includes specification of OPCs in the pMN progenitor domain (Orentas and Miller 1996; Poncet et al. 1996; Pringle et al. 1996; Mekki-Dauriac et al. 2002; Agius et al. 2004; Miller et al. 2004). Shh, acting through its downstream mediators, the Gli proteins, activates transcription of different sets of lineage-determining genes (primarily transcription factors) at different distances from the floor plate (different concentrations of Shh) (Briscoe and Ericson 2001). In the pMN domain, Shh induces the basic helix–loop–helix (bHLH) transcription factor Olig2, which is absolutely required for sequential generation of MNs and OPCs; in Olig2 null spinal cords, the pMN is missing, so MNs and OPCs are absent and the animals die at birth (Lu et al. 2002; Takebayashi et al. 2002; Zhou and Anderson 2002). How can this one transcription factor be responsible for two quite different cell types? In wild-type mice, Olig2 is phosphorylated on serine 147 (Olig2S147) at early times during and before MN production, but is rapidly dephosphorylated at the time pMN switches to OPC production (Li et al. 2011). This causes Olig2 homodimers to fall apart and, instead, to favor heterodimerization with related bHLH proteins, including neurogenin 2 (Ngn2), altering the activity of Olig2 (e.g., by affecting DNA binding) and contributing to the switch of cell fate (Li et al. 2011).

The Notch signaling pathway collaborates with Shh for OPC specification. Notch and its ligands of the Delta/Jagged family participate in cell contact–mediated signaling to induce and maintain differences between developing cells in many parts of the embryo. In the zebrafish ventral neural tube, Notch signaling between committed neuronal precursors and radial glia keeps the latter in a stem-like state, thereby preserving the pool of precursors available to generate OPCs later; inhibiting Notch signaling globally with the drug DAPT leads to a glut of MNs at the expense of OPCs (Park and Appel 2003; Kim et al. 2008). The phenotypes of zebrafish Notch3 loss-of-function mutations are consistent with this interpretation (Zaucker et al. 2013). Experiments in chicks and mice also support this general model and indicate that Jagged2 is a key Notch ligand responsible for holding back OPC production until the time of the MN–OPC switch (Rabadan et al. 2012). Perhaps Notch-Jagged2 signaling, acting via the transcriptional inhibitor Hes5 (Rabadan et al. 2012), regulates the expression or activity of the phosphatase(s) responsible for dephosphorylating Olig2S147. Notch signaling also plays an important role later during development, when OPCs are maturing to OLs and elaborating myelin (Wang et al. 1998; Hu et al. 2003).

There is no floor plate in the forebrain, but Shh is expressed from early times (E10.5 onward in mice) by precursor/stem cells of the MGE and LGE, in which it auto-induces expression of Olig2 and the closely related Olig1 (Nery et al. 2001; Tekki-Kessaris et al. 2001). The Olig-expressing stem cells generate OPCs that migrate throughout the forebrain after ∼E12.5. Olig-positive stem cells also generate neurons, although the lineage relationship among OPCs and forebrain neurons is not well understood. Cholinergic projection neurons, which settle in the ventral forebrain (Furusho et al. 2006), and inhibitory (γ-aminobutyric acid, GABAergic) interneurons, which migrate dorsally to populate the cerebral cortex (He et al. 2001; Yung et al. 2002; Petryniak et al. 2007), are known to descend from Olig-expressing precursors along with OPCs. It is not known whether the phosphorylation state of Olig2S147 plays a role in neuron–OPC switching in the forebrain, as it does in the ventral spinal cord.

Fibroblast growth factor (Fgf) signaling also plays an important role in OPC specification in the ventral telencephalon. There are four Fgf receptors (Fgfr1–4), of which Fgfr1–3 are expressed in the developing CNS. Conditional knockout of either Fgfr1 or Fgfr2 (but not Fgfr3) in the ventral forebrain from ∼E10.5, using Foxg1-Cre, resulted in a reduction in the number of Sox10+, Pdgfra+ OPCs in the ventral telencephalon from E12.5–E16; in Fgfr1/2 double knockouts, OPCs were almost completely absent (Furusho et al. 2011). The expression and activity of Shh were not affected, judging by the continued presence of messenger RNAs (mRNAs) encoding Shh and its receptor Patched (Ptc) (which is transcriptionally activated by Shh) in the ventral telencephalon of the Fgfr1/2 mutants. Inhibitors of either Hedgehog or Fgf signaling block OPC production in cultures of embryonic forebrain cells, pointing to an obligatory collaboration between Shh and Fgf signaling (Kessaris et al. 2004; Furusho et al. 2011). It is known that Fgf and Hedgehog pathways interact in other contexts (reviewed by Stecca and Ruiz 2010).

Both Shh and Fgf function by inducing Olig expression in the neural stem cells on which they act. Olig2 is absolutely required for OPC specification in the spinal cord (Lu et al. 2002; Takebayashi et al. 2002). Olig1 mRNA, although coexpressed with Olig2 in the VZ from before E11, is not translated into protein until ∼E18.5 (Fu et al. 2009), so Olig1 does not contribute to OPC specification in the spinal cord. However, Olig1 can partially compensate for loss of Olig2 in the embryonic brain because some OPCs are generated in the brains of Olig2 null mice, but none are generated in Olig1/Olig2 double knockouts (Lu et al. 2002; Zhou and Anderson 2002).

There is agreement that Olig1 is not required for OPC specification, provided Olig2 is present, but there has been uncertainty over whether Olig1 might play an essential role in later stages of OL development (Lu et al. 2002; Xin et al. 2005). The balance of evidence now suggests that Olig1 is dispensable for OL development and myelination (Paes de Faria et al. 2014), although it appears to be needed for remyelination of demyelinated lesions in the adult CNS (Arnett et al. 2004; also see Emery and Lu 2015).

ARE VENTRALLY AND DORSALLY DERIVED OLs FUNCTIONALLY DISTINCT?

It is likely that ventral sources of OPCs are specified primarily by Shh, but the signals that specify OPCs in the dorsal spinal cord and brain are less well understood. Small numbers of OPCs are produced in the dorsal spinal cord of Nkx6.1/Nkx6.2 double-null mice, in which Shh signaling in the ventral cord is disrupted (Cai et al. 2005; Vallstedt et al. 2005). OPCs also develop in cultures of Shh null embryonic spinal cord (Cai et al. 2005). These and other experiments (Chandran et al. 2003; Kessaris et al. 2004) point to a Shh-independent pathway for OPC specification in the spinal cord, possibly an Fgf family member, but which one or from which cells is unknown.

That dorsally and ventrally derived OPCs are generated independently, by different signals, raises the question of whether the ventral and dorsal “lineages” might produce OPCs that are functionally distinct. This is a potentially important question to answer because it has implications for the design of future cell-based therapies for repair of demyelinating damage. Different morphological subclasses of OLs have been described that myelinate either many small-diameter axons or only one or a few larger-diameter axons (Bjartmar et al. 1994; Butt et al. 1998a; Anderson et al. 1999). Specialized subsets of OLs have also been suggested on the basis of molecular differences (Butt et al. 1998b; Kleopa et al. 2004). However, a link between OL heterogeneity and developmental origin has not been established. In fact, they appear to be interchangeable. When one group of OPCs was ablated at their site of origin using a Cre-inducible diphtheria toxin (DT) transgene targeted to different regions of the embryonic neuroepithelium with Nkx2.1-Cre, Gsh2-Cre, or Emx1-Cre (Kessaris et al. 2006), OPCs from neighboring regions invaded the targeted area and proliferated to fill the void, ultimately achieving a normal distribution of OPCs and mice that were phenotypically normal. Even when practically all telencepalic OPCs were ablated (in mice carrying all three Cre transgenes plus inducible DT), mice recovered within a few weeks after birth, apparently by forward migration of OPCs from the diencephalon (Fig. 2D) (Iannarelli 2014). This illustrates the remarkable developmental plasticity of OL lineage cells and argues against intrinsic differences among OPCs from different embryonic origins.

An equivalent genetic ablation experiment has not been performed in spinal cord because of a lack of suitable Cre lines. However, experiments with mouse reporters, which distinguish dorsal and ventral lineages, have shown that dorsally derived OPCs displace their ventrally derived counterparts from dorsal axon tracts in the spinal cord during postnatal development (Tripathi et al. 2011a) and have a greater propensity to remyelinate demyelinated lesions during adulthood (Zhu et al. 2011a). It is not known whether this is because the dorsal and ventral lineages are intrinsically specialized for different tasks or the dorsal cells are generated slightly later during development and, hence, remain more “youthful” and better able to compete for limiting mitogens or other extracellular signals. It has, so far, not been possible to distinguish dorsally and ventrally derived OPCs by their antigenic or electrophysiological properties (Tripathi et al. 2011; Clarke et al. 2012). Ultimately, genome-wide screens of expressed genes (e.g., by RNA sequencing) in purified populations of dorsal versus ventral OL lineage cells might determine whether different OL subtypes are linked to their developmental origins.

CONTROL OF OL DEVELOPMENT BY POLYPEPTIDE GROWTH FACTORS

When they first appear in the VZ, mammalian and avian OPCs express Pdgf receptors (α-subunit, Pdgfra) and they survive and proliferate in response to Pdgf-AA secreted from neighboring cells (neurons and astrocytes) (Noble et al. 1988; Raff et al. 1988; Richardson et al. 1988; Hart et al. 1989; Pringle et al. 1992). The Pdgf family comprises four related subunits, Pdgf-A, -B, -C, and -D, encoded by separate genes. Active Pdgf is a dimer with the structure AA, BB, AB, CC, or DD; Pdgfra can bind to and be activated by all of these except Pdgf-DD (Reigstad et al. 2005). In Pdgf-A null mice, OPC development is affected more or less severely, depending on the region. The most severely affected areas are optic nerve and spinal cord, in which OPC numbers are reduced >99% and ∼88% at birth; the cerebral cortex and brainstem are less affected (∼80% and ∼60% reduction, respectively) (Fruttiger et al. 1999). Pdgf-BB and/or Pdgf-CC might be responsible for the residual mitogenic activity in regions less affected by loss of Pdgf-A; for example, Pdgf-C is expressed in the developing cerebral cortex (Hamada et al. 2002), although its role in OPC development has not been tested. Pdgf does not act alone, but requires the coparticipation of extracellular matrix (ECM) molecules and their receptors (integrins) for its mitogenic activity; relevant ECM components include the NG2 proteoglycan (Nishiyama et al. 1996) and Tenascin-C (Garcion et al. 2001), and the key integrin combination appears to be αvβ3, which is phosphorylated and becomes mitogenically active in its own right following physical association with ligand-bound Pdgfra (Baron et al. 2002, 2005).

Fgf family members are also mitogenic for OPCs in culture, particularly in cooperation with Pdgf. When cultured in defined medium containing Pdgf-AA, OPCs divide and differentiate into OLs on a similar pattern as in vivo. A fraction of the daughters of cell divisions survive as OPCs, whereas the remainder differentiate into OLs (Raff et al. 1988; Tang et al. 2000). When cultured in Pdgf-AA (or -AB) and basic Fgf (Fgf2), they continue to divide without differentiating for an extended period (Bögler et al. 1990; McKinnon et al. 1990), expanding OPC numbers seemingly indefinitely. Despite this striking effect in vitro, conditional deletion of Fgf receptors has revealed very little involvement of Fgf in controlling OPC proliferation in vivo (see below).

The repertoire of Fgfr's expressed by OL lineage cells changes as OPCs mature and differentiate in vitro (Fortin et al. 2005). Fgfr1 and Fgfr3 are both expressed by purified primary OPCs in culture; signaling through Fgfr1 (e.g., by Fgf2) stimulates proliferation, whereas signaling via Fgfr3 (e.g., by Fgf8) does not affect DNA synthesis or cell division, but inhibits terminal differentiation to OLs (Butt and Dinsdale 2005; Fortin et al. 2005). Despite these findings, conditional deletion of Fgfr1 or Fgfr2 in the ventral telencephalon (using Foxg1-Cre) did not affect OPC proliferation rate in vivo (Furusho et al. 2011). Germline knockout of Fgf2 (expression of which normally increases in the CNS in the second postnatal week) also did not affect OPC proliferation in the developing spinal cord, but increased the number of differentiated OLs, suggesting that signaling through Fgfr1 in OPCs normally inhibits OL differentiation (Murtie et al. 2005). Deletion of both Fgfr1 and Fgfr2 in differentiated OLs (using Cnp-Cre or Olig1-Cre) resulted in reduced activity of the mitogen-activated protein kinase (MAPK) pathway, inhibition of myelin protein synthesis, and thinner myelin sheaths over the long term (Furusho et al. 2012), suggesting that Fgf signaling normally stimulates myelin synthesis by differentiated OLs.

Fgfr3 is strongly expressed by neural stem cells and astrocytes, so that in situ hybridization for Fgfr3 or recombination of a reporter transgene by Fgfr3-CreER preferentially marks those cells, not OPCs (Pringle et al. 2003; Young et al. 2010). Fgfr1/2 (but not Fgfr3/4) are also highly expressed by many neurons, so alteration of Fgf signaling in these cells might indirectly affect OL lineage cells in vivo. Clearly, Fgf signaling in the normal CNS is very complex and could be further modulated by disease or injury in ways that are difficult to predict, and experimentally challenging to investigate, because of the large number of Fgf family members that could potentially be involved (22, at least 18 of which are expressed in the CNS) (Ford-Perriss et al. 2001). The role of FGF signaling in CNS pathology, for example, in the impairment of OL differentiation, which is believed to occur in chronic multiple sclerosis (MS) lesions, is an important research area that warrants further attention.

Epidermal growth factor (Egf) has a profound effect on the production of OPCs in vivo, greatly increasing numbers of OPCs when Egf is delivered into the intact adult CNS and significantly improving the repair of demyelinating damage caused by gliotoxin injection or perinatal ischemia (Cantarella et al. 2008; Scafidi et al. 2014). In this context, Egf is likely to act by steering SVZ stem cells away from their default fate (generation of olfactory interneurons) toward production of glial cells, including OPCs (Sun et al. 2005; Cantarella et al. 2008; Gonzalez-Perez and Alvarez-Buylla 2011). In keeping with this interpretation, SVZ stem cells express high levels of the Egf receptor (Egfr, ErbB1), whereas OPCs do not (Chojnacki and Weiss 2004; Sun et al. 2005; Cahoy et al. 2008), and Egf has been reported not to stimulate proliferation of OPCs or other neural cells outside of the SVZ in slice culture (Hill et al. 2013).

A large number of other polypeptides and their receptors have been reported to influence proliferation, differentiation, and/or survival of OL lineage cells. These include members of the transforming growth factor (Tgf)-β/bone morphogenetic protein (Bmp) family (See and Grinspan 2009; Dutta et al. 2014; Palazuelos et al. 2014), insulin-like growth factor-1 (McMorris et al. 1986; D’Ercole and Ye 2008), neuregulins (Canoll et al. 1996; Vartanian et al. 1999; Fernandez et al. 2000; Carteron et al. 2006; Brinkmann et al. 2008; Taveggia et al. 2008; Ortega et al. 2012), Wnts (Shimizu et al. 2005; Fancy et al. 2009; Ye et al. 2009; Langseth et al. 2010; Dai et al. 2014), neurotrophin-3 (Barres et al. 1993; Cohen et al. 1996), chemokines (Robinson et al. 1998; Dziembowska et al. 2005; Göttle et al. 2010), ciliary neuronotrophic factor (Barres et al. 1993), brain-derived neurotrophic factor (Vondran et al. 2010; Wong et al. 2013), transferrin (Silvestroff et al. 2013), erythropoetin (Sugawa et al. 2002), thyroid hormone (TH; triiodothyronine) (Walters and Morell 1981; Barres et al. 1994; Ahlgren et al. 1997; Rodriguez-Pena 1999), retinoic acid (Barres et al. 1994; Noll and Miller 1994), and others. Most of these factors influence the differentiation of OLs and/or their subsequent survival including, perhaps especially, during demyelination and remyelination. Apart from diffusible or contact-mediated signals such as these, there has been an explosion of interest in the regulatory roles played by electrical signals between neurons and OL lineage cells. This is discussed in detail below (see section Axoglial Synaptic Signaling and Development).

OL POPULATION DYNAMICS AND HOMEOSTASIS IN VIVO

OPCs proliferate when cultured in defined medium containing Pdgf. If passaged in medium lacking TH, they proliferate for many generations without differentiating (Barres et al. 1994), but if TH is present, cell division and differentiation occur simultaneously, apparently recapitulating OL lineage development in vivo (Tang et al. 2000). When single OPCs are cultured on their own with Pdgf and TH, they divide a predictable number of times before all progeny differentiate into OLs (Temple and Raff 1985). The younger the tissue from which OPCs are isolated, the more divisions they undergo before differentiating, giving rise to the idea that OPCs have an intracellular timer that determines when they should stop dividing and differentiate (Temple and Raff 1986; Durand and Raff 2000). This timer apparently requires Pdgf to keep it running and TH to trigger differentiation at the allotted time (Barres et al. 1994; reviewed by Durand and Raff 2000). However, clonal analysis in mixed cell cultures (Zhang and Miller 1995; Ibarrola et al. 1996) or live mice (Zerlin et al. 2004; Kang et al. 2010; Zhu et al. 2011) shows that the progeny of a given proliferating OPC do not necessarily differentiate synchronously as they do in single-cell culture; clones of OL lineage cells frequently contain both cycling OPCs and myelinating OLs. Temporal and spatial control of differentiation in vivo is complex; the cell-intrinsic timing program in OPCs is presumably controlled and modified by signals from neighboring cells. What is the nature of those signals?

When Pdgf is withdrawn from OPC cultures that contain TH in the medium, all OPCs stop dividing together and differentiate into OLs (Durand and Raff 2000). This is accompanied by rapid down-regulation of Pdgfra, but the latter is thought to be a consequence of differentiation, not the trigger (Hart et al. 1989). Nevertheless, it could be diminishing activity of the Pdgf signaling pathway upstream of or downstream from the receptor that leads OPCs to exit the cell cycle and differentiate in vivo. The cell division rate of OPCs declines during embryonic development, cell-cycle time increasing from ∼24 h in the E12.5 mouse spinal cord to >100 h at E17 (van Heyningen et al. 2001), and this seems to be a consequence of declining Pdgf signaling because the cell cycle of E17 OPCs is accelerated by placing them in dissociated cell culture with saturating concentrations of Pdgf (van Heyningen et al. 2001). Overexpressing Pdgf-A in transgenic mice under the control of an astrocyte or a neuron-specific promoter (astrocytes and neurons are normal sources of Pdgf-A) leads to an increase in the population density of OPCs in the white or gray matter, respectively (Fig. 1H,I) (Calver et al. 1998; Fruttiger et al. 2000; van Heyningen et al. 2001). Moreover, in Pdgf-A+/− embryos, the density of OPCs is reduced to ∼50% of normal (van Heyningen et al. 2001), showing that the normal density of OPCs in vivo (at least in the spinal cord) is determined by the Pdgf supply, not solely by cell-intrinsic mechanisms. Remarkably, the cell-division rate of OPCs, at steady state, was found to be the same in different transgenic lines with different levels of Pdgf-A expression (Calver et al. 1998; van Heyningen et al. 2001). This led to the proposal that the population density of OPCs is determined by the balance between the rate of provision of Pdgf (by neurons and/or astrocytes) and the rate of consumption by OPCs themselves, that is, the OPC population expands until the rate at which it removes Pdgf from the system by receptor binding and internalization matches the rate of supply. At that point, any further increase in the number of OPCs reduces the Pdgf concentration below the limit required to prevent OPCs from exiting the cell cycle; some OPCs then differentiate, down-regulating Pdgfra and reducing demand for Pdgf. This, in turn, allows Pdgf to rise above the threshold for cell division, and so on, leading to a stable steady state (van Heyningen et al. 2001).

Although this “supply and demand” model can explain why the cell cycle slows down as the number of OPCs increases during embryonic development, it does not explain what causes OPC proliferation to continue slowing during postnatal life while the OPC number remains roughly constant (Rivers et al. 2008; Young et al. 2013). For example, the cell cycle of OPCs in the corpus callosum slows from ∼3 d at P21, to ∼10 d at P60, to >100 d at P240 (Psachoulia et al. 2009; Young et al. 2013). If, for example, there was a diminishing rate of Pdgf synthesis and secretion with age of the animal, then, according to the supply-and-demand model, there should be a decline in the number of OPCs per unit volume, but ultimately no change in division rate. The persistent slowing could be explained by a diminishing mitogenic responsiveness of OPCs to Pdgf, and a parallel reduction in their rate of differentiation (or they would all differentiate and the OPC population would be depleted). This returns us to the idea of a cell-intrinsic timer, not one that triggers synchronous differentiation after a fixed time, but one that controls cell-cycle transition probabilities, from G1 → S and from G1 → G0. There might be a steady accumulation with age of intracellular activities that inhibit cell-cycle progression, such as the inhibitory proteins p27Kip1 and p57Kip2 (Durand et al. 1998; Durand and Raff 2000; Dugas et al. 2007), coupled with diminishing activity of differentiation-inducing or -permissive pathways (Tokumoto et al. 2001; Billon et al. 2004).

OPCs assume a bipolar shape and migrate radially and tangentially into the developing spinal cord and brain as they exit their germinal zones. The factors that promote their dispersion are not well understood, but are likely to involve contact-mediated interactions using molecules similar to those that guide neuronal migration, including Netrin/DCC/Unc5, Semaphorin/Neuropilin, and Ephrin/Eph (de Castro and Bribian 2005). For example, in the embryonic spinal cord, Netrin-1 is secreted by the floor plate, whereas OPCs express the Netrin-1 receptors DCC and UNC5. Netrin-1 repels OPCs in vitro (Tsai et al. 2003) and mice deficient in Netrin-1 show impaired dorsoventral migration of OPCs (Jarjour et al. 2003). OPCs also express the Neuropilin 1 receptor and its ligand Sema3A repels OPCs in vitro (Sugimoto et al. 2001; Spassky et al. 2002; Syed et al. 2011); they also express Neuropilin 2, and its ligand Sema3F attracts OPCs. Nevertheless, persistent OPC migration deficits have not been observed in mice lacking these individual components, suggesting that there may be several redundant pathways that regulate their early migration. Growth factor availability and repulsion brought about by increases in OPC density also influence their dispersion. In Pdgfra null mice, the proliferation of OPCs is inhibited and dispersion is reduced, resulting in profound deficits in myelination in most regions of the CNS (Fruttiger et al. 1999). This suggests that Pdgf not only promotes proliferation, but also enables cell movement, perhaps by forcing repulsive interactions (see below).

Gray matter OPCs show a radial morphology, extending highly ramified processes ∼25 µm into the surrounding neuropil, whereas, in white matter, their processes are oriented parallel to traversing axons. Time-lapse imaging of fluorescently labeled OPCs in the upper layers of the cortex using two-photon microscopy has revealed that these cells are not static, but continuously reorient their processes and move through the brain parenchyma at an average rate of 2 µm/d (Hughes et al. 2013). Each OPC process is studded with numerous filopodia, which extend and retract on a timescale of seconds, and dynamic growth cones are visible at the leading edge of extending processes. This behavior is reminiscent of the scanning behavior shown by microglia (Davalos et al. 2005; Nimmerjahn et al. 2005) and suggests that OPCs actively survey their local environment. When a filopodium makes contact with an adjacent process on the same cell, or on a neighboring cell, it invariably retracts. This powerful self-inhibition provides a means for OPCs to maintain discrete territories despite their active growth. By analogy to amacrine cells in the retina, which show a similar radial morphology and tiling, these repulsive cues might not only control cell spacing, but might also establish and maintain nonoverlapping, radially oriented processes on each cell (Kay et al. 2012). Expression profiling has revealed that OPCs express transcripts for proteins implicated in controlling dendritic spacing and cell body position in neurons (Cahoy et al. 2008), but the repulsive cues used by OPCs, whether secreted or membrane bound, remain to be determined.

OPCs IN THE ADULT CNS: ROLES IN HEALTH AND DISEASE

A large population of Pdgfra+, NG2+ OPCs persists beyond perinatal development into adulthood when they comprise ∼5% of all neural cells; these are distributed nearly uniformly throughout the brain and spinal cord in both white and gray matter (Fig. 3A) (Pringle et al. 1992; Chang et al. 2000; Dawson et al. 2003). This was initially a surprise and “adult OPCs” came under scrutiny as a novel glial cell type in their own right (Berry et al. 2002; Butt et al. 2002; Greenwood and Butt 2003). When encountered by physiologists, they were often confused with astrocytes, and they referred to them as “complex astrocytes” or “GluR astrocytes.” OPCs are the major proliferating cell type in the mature CNS (Dawson et al. 2003), yet their numbers remain more-or-less constant during postnatal life (Rivers et al. 2008), raising the question of what becomes of their excess progeny. The answer must be that half of the daughters of each OPC cell division, on average, either differentiate or die. The realization that there are dividing multipotent stem cells in the adult SVZ and hippocampus fueled speculation that OPCs might be yet another population of stem cells with broad differentiation potential. However, genetic lineage-tracing experiments in mice (using tamoxifen-inducible CreER) indicate that OPCs are lineage restricted and overwhelmingly generate OLs in adulthood (Fig. 3B,C) (Dimou et al. 2008; Rivers et al. 2008; Kang et al. 2010; Zhu et al. 2011b). Following injury or disease, the situation might change slightly, as several studies indicate that adult OPCs can expand to include some astrocytes (glial fibrillary acidic protein [GFAP] expressing) and also myelinating Schwann cells (Dimou et al. 2008; Barnabé-Heider et al. 2010; Tripathi et al. 2010; Zawadzka et al. 2010; Komitova et al. 2011), although the majority of differentiated progeny are still OLs (reviewed by Richardson et al. 2011; Franklin and Goldman 2015). A notable exception is a report (Tatsumi et al. 2008) that Olig2+ OPCs generate exclusively protoplasmic astrocytes following freeze–thaw damage to the cerebral cortex. This result might be explained if Olig2 function was compromised somehow (e.g., by cold) because inactivating Olig2 in OPCs using NG2-Cre has been shown to cause cortical OPCs to develop into protoplasmic astrocytes rather than OLs (Zhu et al. 2012).

Figure 3.

Figure 3.

OPCs persist in the adult CNS. (A) In situ hybridization for Pdgfra reveals many OPCs scattered more or less uniformly throughout the adult brain (∼20-μm section). The inset shows a region of the cortex (marked by a rectangle) at higher magnification. (B) These adult OPCs continue to divide and generate myelinating oligodendrocytes (OLs) in the gray and white matter throughout at least the first year of life in mice (newborn OLs visualized in Pdgfra-CreERT2: Tau-mGFP transgenic mice, recombination induced by tamoxifen injection on P60 and analyzed 1 mo later. (Image kindly provided by Dr. Sarah Jolly.) (C) Adult-born (after P120, lower panel) OLs in the optic nerve have shorter internodes, but many more of them than OLs born earlier (e.g., after P30, upper panel). Tamoxifen was injected at P30 or P120 and the animals analyzed after 30 or 65 d, respectively. Adult-born OLs frequently also have one or two very long internodes (yellow arrows), which might represent first-time myelination of the very small number of unmyelinated axons present in the adult optic nerve. (D) Distributions of internode lengths of OLs born after P30 (red) or P120 (black). (Panels C and D from Young et al. 2013; reprinted, with permission, from Elsevier Limited © 2013.)

The in vivo fate-mapping experiments described are something of a setback for the hope that OPCs might represent a distributed pool of multipotent stem cells that can potentially be steered into a range of neural lineages to replace neurons, which are lost during neurodegenerative diseases. Nevertheless, there has been a recent report that OPCs can produce new neurons in the adult hypothalamus (Robins et al. 2013), potentially contributing to the function of circuits that control body homeostasis (e.g., appetite and satiety). Previous reports that OPCs might generate small numbers of new projection neurons in the adult piriform cortex (olfactory cortex) (Rivers et al. 2008; Guo et al. 2010) were not substantiated subsequently (Kang et al. 2010; Clarke et al. 2012).

Despite the perpetual loss and addition of OPCs in the adult CNS through cell death and differentiation, their numbers remain remarkably constant. How is this homeostasis achieved? Although new OPCs can be generated from SVZ progenitors (Jablonska et al. 2010), particularly following demyelination, maintenance of the OPC population in the normal brain appears to rely primarily on local interactions: in vivo imaging indicates that loss of one cell through differentiation, apoptosis, or laser-ablation is accompanied by rapid division of an immediately adjacent OPC (Fig. 4A–D) (Hughes et al. 2013). These observations suggest that all OPCs have the capacity to enter the cell cycle, and replacement is achieved, not by mobilizing SVZ progenitors or by the actions of a subset of highly proliferative OPCs, but rather through the homeostatic behavior of all members of the population. This is consistent with the fact that 100% of OPCs can incorporate the thymidine analogs BrdU or EdU if provided for a sufficient length of time (Kang et al. 2010; Young et al. 2013). It is not known what determines which of the many surrounding OPCs will divide after ablation of one of their number; however, OPC division is typically preceded by enhanced growth of a neighboring OPC into the territory of the lost OPC (Fig. 4D), raising the possibility that cell size, polarization, or enhanced access to mitogens, such as Pdgf (van Heyningen et al. 2001), could be the trigger for cell division (see section OL Population Dynamics and Homeostasis In Vivo).

Figure 4.

Figure 4.

Synaptic signaling between neurons and oligodendrocyte precursor cells (OPCs). (A) Electron micrograph from a rat hippocampal brain slice in which one physiologically defined OPC was loaded with biocytin during a whole-cell recording and processed for peroxidase. A process of this cell (red asterisk) is visible as a postsynaptic partner to an axon terminal. (B) Whole-cell voltage-clamp recording from an OPC in the molecular layer of the cerebellum, showing the response to stimulation of a climbing fiber in control conditions, when cyclothiazide (CTZ) was used to block AMPA-receptor desensitization, and AMPA receptors were blocked with GYKI 53655. (C) Miniature excitatory postsynaptic currents (mEPSCs) recorded in the presence of tetrodotoxin (to block action-potential-dependent release of glutamate) from an OPC in the molecular layer of the cerebellum. Inset at bottom left shows the average mEPSC waveform and a single exponential fit (tau) to the rapid decay of the mEPSC. (D) Current-to-voltage relationship of EPSCs elicited in cerebellar OPCs by climbing fiber stimulation (open circles). Inclusion of the polyamine spermine increased inward rectification (filled circles), a hallmark of Ca2+-permeable AMPA receptors. Inset at top left shows selected responses from each configuration. (EG) Fluorescent images of OL lineage cells at different stages of maturation. Cells were filled with neurobiotin through the whole-cell electrode. The membrane properties of the cells are shown in the inset in the upper left. (HJ) Recordings of mEPSCs elicited in OPCs, premyelinating OLs (pre-OL) and mature OLs, by focal application of hypertonic solution during the indicated time periods (black bars). Note that mEPSCs are only observed in cells in the OPC stage. (Panel A adapted from Bergles et al. 2000; panels BD from Lin et al. 2005; reproduced, with permission, from Elsevier Limited © 2005; panel E based on data from De Biase et al. 2010.)

The maintenance of OPCs in the adult CNS, and their near-complete coverage of the neuropil through tiling, might enable OPCs to monitor the local state of myelination and respond rapidly to demyelination or if there were a physiological demand for new myelin (see section Adaptive Myelination in Adulthood). Given this powerful homeostasis, it is surprising that the density of OPCs is substantially reduced in many demyelinated lesions from postmortem MS patients (Lucchinetti et al. 1999; Chang et al. 2000; Boyd et al. 2013), indicating that their homeostatic control is disrupted. If local interactions are required to detect demyelination, this loss of cells could influence the timing and extent of OL regeneration. Recent studies suggest that changes in the expression of Sema3A and Sema3F might contribute to this impaired recruitment (Boyd et al. 2013). Changes in the composition of the ECM within lesions and local exposure to cytokines might also alter their capacity to maintain their population density within lesions. Understanding the hierarchy of these signaling pathways and their spatial and temporal control will be required to comprehend their combined influences on myelin repair.

OPCs retain some of their progenitor characteristics in the adult CNS, including the ability to proliferate and migrate, features that might be crucial for detecting injury and mounting a rapid reparative response. However, preserving cells with these characteristics throughout life also carries significant risk, as OPCs appear to be particularly prone to transform to a state of uncontrolled growth. The expression of OL lineage genes by cells in some human gliomas (Robinson et al. 1998; Dougherty et al. 2012) has led to the suggestion that OPCs are a cell of origin for some CNS tumors. Indeed, deletion of the tumor suppressor genes P53 and the neurofibromatosis-related protein NF-1, or expression of an activated allele of the EGF receptor (v-erbB) within OPCs, triggers hyperproliferation and tumor formation (Persson et al. 2010; Liu et al. 2011). Moreover, direct injection or transgenic overproduction of Pdgf also leads to gliomas that contain cells with features of OPCs (Assanah et al. 2006; Lindberg et al. 2009; Persson et al. 2010; Nazarenko et al. 2011), suggesting that even genetically normal OPCs can be transformed when presented with surplus mitogens (also see Fig. 1H,I). A key step in their transformation might be down-regulation of pathways responsible for self-repulsion or the ability of growth factors to override self-repulsion. From an evolutionary perspective, it appears that the benefits provided by these cells in the adult CNS outweigh the risks associated with their propensity to transform into cancer cells.

AXOGLIAL SYNAPTIC SIGNALING AND DEVELOPMENT

The initial characterization of OPCs (then known as O-2A progenitors) in vitro revealed that they express a variety of receptors for neurotransmitters, including glutamate (both AMPA and N-methyl-d-aspartate [NMDA] receptors), GABA, and acetylcholine (Barres et al. 1990; Wyllie et al. 1991), observations that were confirmed by recording from OPCs in acute brain slices (Jabs et al. 1994; Steinhäuser et al. 1994) and gene expression profiling (Patneau et al. 1994; Seifert et al. 1997; Cahoy et al. 2008). These discoveries indicated that neurotransmitters might be used to alter the behavior of OPCs in response to the demands of surrounding neurons. OPCs also express a diverse complement of voltage-gated ion channels, including Na+, K+, and Ca2+ channels (reviewed by Bergles 2012) and, early in development when their membrane resistance is high, they can generate small Na+-dependent spikes when depolarized (Chittajallu et al. 2004; Káradóttir et al. 2008; De Biase et al. 2011). Moreover, OPCs appear to be the only glial cells that form direct synapses with neurons. OPCs form synapses with glutamatergic neurons in all gray and white matter regions that have been examined, including the hippocampus (Bergles et al. 2000; Jabs et al. 2005), cerebellum (Lin et al. 2005), cortex (Chittajallu et al. 2004), brainstem (Muller et al. 2009), and white matter tracts (Káradóttir et al. 2005; Kukley et al. 2007; Ziskin et al. 2007). In gray matter, they also form synapses with GABAergic neurons (Lin and Bergles 2004; Jabs et al. 2005; Mangin et al. 2008; Tanaka et al. 2009; Velez-Fort et al. 2010), suggesting that synaptic signaling is an important and highly conserved property of OPCs. Glutamatergic axon–OPC synapses are formed early in development and become more robust (larger currents, more abundant inputs) with age, paralleling the normal development of synapses that occurs in surrounding neurons, whereas GABAergic signaling in the cortex changes from synaptic to extrasynaptic with age (Velez-Fort et al. 2010). Unlike neurons, which participate in circuits as both presynaptic and postsynaptic partners, OPCs appear to be exclusively postsynaptic and receive input from neurons, rather than the reverse.

What is the evidence that OPCs engage in direct synaptic communication with neurons? There is both morphological and physiological evidence. In electron micrographs, discrete physical contacts between axons and OPC processes have been observed; at these sites, the axon and OPC membranes are rigidly aligned and separated by electron dense material and clusters of synaptic vesicles are found near the presynaptic membrane (Fig. 5A) (Bergles et al. 2000; Kukley et al. 2007; Ziskin et al. 2007; Haberlandt et al. 2011). Electrical stimulation of axons induces inward currents in nearby voltage-clamped OPCs that begin with minimal delay and show rapid increase and decay kinetics, comparable to excitatory postsynaptic currents recorded in neurons (Fig. 5B). These events are blocked by AMPA receptor-specific antagonists and are sensitive to compounds that modulate AMPA receptor kinetics (e.g., cyclothiazide); in appropriate conditions, GABAergic synaptic events can also be induced. Interestingly, activation of GABA-A receptors induces depolarization rather than hyperpolarization as a result of their high intracellular Cl concentration, as seen in immature neurons (Lin and Bergles 2004; Tanaka et al. 2009). Moreover, spontaneous, quantal miniature excitatory postsynaptic currents (mEPSCs) are visible in these cells when axonal action potentials are blocked, indicating that the amount of glutamate in a single synaptic vesicle is sufficient to induce rapid, synchronous activation of AMPA receptors, showing that glutamate is released in close proximity to these receptors (Fig. 5C).

Figure 5.

Figure 5.

Homeostatic control of OPC density in the adult CNS. (A,B) Images of fluorescently labeled OPCs in the adult mouse somatosensory cortex (NG2-mEGFP mouse), collected using two-photon imaging through a cranial window. Individual cells have been digitally extracted from image stacks and pseudocolored. (A) Differentiation of the green cell is accompanied by division of the immediately adjacent blue cell to maintain a constant density of OPCs. (B) Death of the red cell is accompanied by division of the immediately adjacent blue cell; note that one of the blue sister cells migrates into the territory formerly occupied by the red cell. Time in days (d) is represented in the upper right corner. (C) Graph of the percentage of time that differentiation (white bar) or death (black bar) was associated with proliferation of an immediately adjacent OPC; the gray bar is the chance of observing proliferation of a neighbor. (D) Fluorescent image of three pseudocolored OPCs in vivo, as described above. Ablation of the yellow and magenta OPCs using the Ti:Sapphire laser–triggered division of the adjacent green OPC. h, hour. (E) Laser ablation of multiple OPCs triggers local proliferation and migration of nearby OPCs to fill the voids left by the ablated cells. Green dots represent the positions of the cell bodies of individual OPCs, red dots/lines represent the cell body positions after cell ablation. Cells targeted for ablation are circled in blue. (Adapted from data in Hughes et al. 2013.)

Remarkably, OPCs retain synapses even during cell division (Kukley et al. 2008; Ge et al. 2009), which occurs through a fission-like process that allows each of the two daughter cells to inherit half of the original processes (Hughes et al. 2013). Nevertheless, because OPCs continually reorient their processes as they move through the parenchyma, whereas axons are stable and immobile (De Paola et al. 2006), it appears that these axon–OPC synapses must be transient structures. They are also transient within the lineage. AMPA and NMDA receptor expression is rapidly down-regulated and synapses are removed when OPCs begin to differentiate, indicating that the precursor stage is uniquely specialized to engage in rapid communication with neurons (De Biase et al. 2010; Kukley et al. 2010). In neurons, excitatory synapses induce depolarization to allow Ca2+ influx through NMDA receptors and voltage-gated Ca2+ channels, and initiate action potentials to induce changes in synaptic strength, gene expression, and to enable rapid transfer of information. The function of these inputs to OPCs is less clear. The resting membrane potential of OPCs is close to the equilibrium potential for K+ (∼−90 to −100 mV), that is, ∼20 mV more negative than in neurons, and unitary synaptic events elicit only small depolarizations. Moreover, OPCs are not excitable, in general, and do not possess an axon; thus, they do not appear to play a conventional role in neuronal circuits. However, AMPA receptors expressed by OPCs in some brain regions (Lin et al. 2005) show high Ca2+ permeability (Fig. 5D), resulting from expression of the GluA2 (GluR2) AMPA receptor subunit, which might enable signal transduction without substantial depolarization, and NMDA receptors expressed by these cells show reduced Mg2+ sensitivity, allowing Ca2+ influx at more negative potentials (Káradóttir et al. 2005). Indeed, activation of these NMDA receptors on OPCs can induce changes in the composition and abundance of AMPA receptors (Ge et al. 2006). The latter are also modulated by the Cornichon and TARP accessory proteins (Zonouzi et al. 2011; Coombs et al. 2012), which control the trafficking and kinetics of AMPA receptors in neurons, so axon–OPC synapses appear to have considerable capacity for modification.

Studies in vitro in dissociated cells or brain slices indicate that stimulation of AMPA receptors with exogenous agonists reduces OPC proliferation, whereas blocking AMPA receptors inhibits differentiation (Gallo et al. 1996; Yuan et al. 1998; Gudz et al. 2006). However, these pharmacological manipulations are unable to distinguish between effects on OPCs and effects on neurons, as both cell types express similar receptors. Selective genetic knockout in OL lineage cells of the GluN1 (NR1) subunit, which is required to form functional NMDA receptors, did not alter the proliferation of OPCs or their morphology, density, or distribution, their ability to differentiate, or to generate myelinating OLs (De Biase et al. 2011; Guo et al. 2012). However, OPCs deficient in NMDA-receptor signaling had slightly higher AMPA Ca2+ permeability (De Biase et al. 2011), suggesting that NMDA receptors might play a role in activity-dependent modification of neuron-OPC signaling. Note that the expression of functional NMDA receptors is substantially lower in OPCs than in neurons and NMDA receptor contributions to synaptic responses have not been reported, raising the possibility that these receptors are primarily extrasynaptic. Determining the role of AMPA receptor signaling through similar genetic manipulations is more challenging, as they are tetrameric receptors formed from combinations of subunits encoded by four distinct genes, all of which appear to be expressed by OPCs (Seifert et al. 1997; Cahoy et al. 2008), and, unlike NMDA receptors, functional homomeric receptors can be formed by combining individual subunits.

Why would OPCs use synapses for signaling, given the high energetic cost of expressing the many proteins required to form these connections and the need to continually dissolve and reform synapses because of the OPC’s migratory behavior? The formation of transient synapses by OPCs allows them, periodically, to sample the patterns of activity of axons in their immediate vicinity. Unlike volume transmission, which is used by neuromodulatory transmitters (e.g., norepinephrine and serotonin) that are released at a distance to produce general changes in cellular activity, synapses enable highly specific, exclusive interactions between partners, allowing the postsynaptic cell to monitor and be influenced by continuously changing patterns of activity in the presynaptic cell. It has been known for a long time that blocking action potential propagation with the sodium channel blocker tetrodotoxin (TTX) can inhibit developmental myelination (Barres and Raff 1993; Demerens et al. 1996), and, conversely, artificial or physiological stimulation of neural circuits in adulthood can stimulate OPC proliferation and production of myelinating OLs along the active pathways (Li et al. 2010; Simon et al. 2011; Gibson et al. 2014; McKenzie et al. 2014). Electrical activity can also stimulate local myelin protein synthesis, leading to thickening of the myelin sheaths (decreased G ratios) in active fiber tracts (Wake et al. 2011; Gibson et al. 2014). However, it is not yet known whether axon–OPC synapses are involved in this regulation. Apart from their predominant role in electrical communication, synapses can also provide an entry-point for retrograde signals, such as growth factors (e.g., BDNF) or neuromodulators (e.g., endocannabinoids), as well as being foci for reciprocal cell–cell signaling (e.g., by integrins), potentially influencing the presynaptic cell to enhance or diminish axon excitability, speed of action potential transmission, axonal sprouting, or myelination. Future in vivo studies involving selective disruption of synaptic signaling in OPCs, for example, by selectively interfering with neurotransmitter receptors, will allow us to start teasing apart these complexities.

ADAPTIVE MYELINATION IN ADULTHOOD

A substantial proportion (∼40%) of newly generated OLs in adult white matter go on to myelinate axons and survive long term. This occurs not only in the adult mouse corpus callosum, which contains many unmyelinated axons (∼70% of the total), but also in the adult optic nerve, which contains almost exclusively (>98%) myelinated axons (Fig. 3C,D) (Young et al. 2013). New OLs might be required in the optic nerve (and elsewhere) to replace myelin that is lost through natural OL death or internode shedding. The lifetime of OLs in the normal healthy CNS is not known, but it is generally assumed that they survive for most of the animal’s lifetime, in keeping with the observation that OLs continue to accumulate with age (McCarthy and Leblond 1988; Sandell and Peters 2002). It is also not known whether OLs can shed or add internodes over the long term, although there is evidence suggesting that differentiating OLs generate all their internodes within a rather narrow time window and do not alter much after that (Watkins et al. 2008; Czopka et al. 2013; Young et al. 2013). In the optic nerve, myelinating OLs that are formed during adulthood have a distinctive morphology with many more, shorter internodes than those born in the early postnatal period (Fig. 3D) (Young et al. 2013). This is consistent with previous observations that average internode length decreases (Lasiene et al. 2009) and the number of nodes per unit volume increases (Peters and Kemper 2012) with the age of the animal, and suggests that late-forming OLs might intercalate new internodes among the earlier-formed internodes, perhaps initiating myelination from nodes of Ranvier to create two nodes from one. The functional or behavioral consequences of remodeling myelin in this way are unknown and difficult to predict. It might be that the conduction velocity of action potentials needs to be continually and minutely adjusted, particularly in pathways like the visual and auditory systems, which depend on rapid and synchronous information transfer and processing (reviewed by Kimura and Itami 2009). In the auditory system, for example, there is evidence that microsecond timing is achieved by dynamic adjustment of myelin internode length and thickness (Seidl et al. 2014).

Although most of their internodes are short, many adult-born OLs in the optic nerve produce one or two much longer internodes (>200 μm), which might ensheath the very small number of previously unmyelinated axons that are present in the adult nerve (Young et al. 2013). This would be expected to accelerate action potential propagation along those newly myelinated axons. If de novo myelination were a common function of adult-born OLs elsewhere in the CNS, in which there is a much larger proportion of unmyelinated axons, it would greatly alter the properties of the circuits involved and could contribute significantly to neural plasticity. There is a growing body of evidence from magnetic resonance imaging (MRI) in human subjects that structural changes in white matter, possibly including myelin production or remodeling, are associated with some types of learning, particularly learning motor skills, such as playing a musical instrument or juggling (Bengtsson et al. 2005; Scholz et al. 2009; reviewed by Zatorre et al. 2012). Practicing a motor task presumably involves repetitive firing of nascent or preformed neural circuits, which elicit the required sequence of movements. The new pattern of firing, at some threshold, might trigger new myelin synthesis by preexisting OLs within the circuit, or production of new myelinating OLs, or both. This could be mediated by activity-dependent synaptic or extrasynaptic communication mechanisms, reviewed in the previous section (Axoglial Synaptic Signaling and Development).

A recent study showed that rats trained in a unilateral reaching/grasping task developed MRI changes in the subcortical white matter on the contralateral side, as well as changes in the overlying gray matter (Sampaio-Baptista et al. 2013). Increased MBP immunolabeling was detected in the area of the altered MRI signal, suggesting that the learning task triggered new myelin synthesis. It has now been shown that motor-skills learning is dependent on new myelination (McKenzie et al. 2014). OL production and myelination was blocked in adult mice by conditional deletion of the transcription factor myelin regulatory factor (Myrf) in OPCs, by combining an Myrf(flox) allele with a tamoxifen-inducible Pdgfra-CreER transgene. After tamoxifen treatment, OPCs were effectively prevented from differentiating into new myelinating OLs, whereas preexisting OLs and myelin were unaffected. This prevented the mice from learning a new motor skill (learning to run at speed on a wheel with unevenly spaced rungs) without affecting their ability to recall and perform the same skill if it was acquired before tamoxifen treatment. Wheel running alters the dynamics of OPC proliferation and OL production (Ehninger et al. 2011; Simon et al. 2011; McKenzie et al. 2014), although it remains unclear whether this is primarily a response to exercise, novel experience, or both. Sleep is known also to be important in motor learning and memory consolidation; possibly related to this, OPC proliferation and differentiation have been reported to follow the circadian cycle (Matsumoto et al. 2011; Bellesi et al. 2013).

It is becoming clear that OL genesis, maturation, and myelination during adulthood is a dynamic, regulated process that continually adapts and refines CNS circuitry in response to diverse physiological demands and influences. Central myelination is sensitive to social experience (Liu et al. 2012; Makinodan et al. 2012), enriched environment (Zhao et al. 2012), exercise (Ehninger et al. 2011; Simon et al. 2011), pregnancy (Gregg et al. 2007), and other influences (reviewed by Fields 2008; Richardson et al. 2011; Wang and Young 2014). The realization that OL development continues lifelong and is crucial for healthy brain function and plasticity, as well as for myelin repair in MS and other demyelinating conditions, adds further excitement and urgency to the task of exploring which of many complex pathways regulate OPC behavior in vivo under different physiological and pathological conditions. Compelling questions to be addressed include: What are the biological consequences of axon–OPC synaptic and extrasynaptic signaling? To what extent do the MRI changes observed during motor learning and other physiological processes reflect changes to OLs and myelin? Is adult myelination required for, for example, spatial and episodic (hippocampus-dependent) learning? How might we stimulate adult myelination to assist motor skills learning and prevent age-related motor and cognitive decline? What prevents remyelination of chronic MS demyelinated lesions and how can we overcome remyelination block? The development of new genetic tools and a greater understanding of the molecular characteristics of OPCs in the adult CNS will begin to yield answers to these important questions.

ACKNOWLEDGMENTS

The authors thank their respective laboratory members for helpful discussions, suggestions, and their efforts in obtaining many of the results described in this review. We thank Dr. Pantelis Tsouflas (University of Miami) for providing an image of human fetal spinal cord (Fig. 1D). We apologize to the many investigators whose important contributions have been omitted as a result of space considerations. Recent work in W.D.R.’s laboratory is supported by the UK Medical Research Council, the Wellcome Trust, the European Research Council (Grant agreement 293544), the Royal Society, and the Alzheimer’s Society UK. Work in D.E.B.’s laboratory is supported by the National Institutes of Health, the National Multiple Sclerosis Society, and Target ALS.

Footnotes

Editors: Ben A. Barres, Marc R. Freeman, and Beth Stevens

Additional Perspectives on Glia available at www.cshperspectives.org

REFERENCES

*Reference is also in this collection.

  1. Agius E, Soukkarieh C, Danesin C, Kan P, Takebayashi H, Soula C, Cochard P. 2004. Converse control of oligodendrocyte and astrocyte lineage development by Sonic hedgehog in the chick spinal cord. Dev Biol 270: 308–321. [DOI] [PubMed] [Google Scholar]
  2. Ahlgren SC, Wallace H, Bishop J, Neophytou C, Raff MC. 1997. Effects of thyroid hormone on embryonic oligodendrocyte precursor cell development in vivo and in vitro. Mol Cell Neurosci 9: 420–432. [DOI] [PubMed] [Google Scholar]
  3. Anderson ES, Bjartmar C, Westermark G, Hildebrand C. 1999. Molecular heterogeneity of oligodendrocytes in chicken white matter. Glia 27: 15–21. [PubMed] [Google Scholar]
  4. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ, Stiles CD. 2004. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306: 2111–2115. [DOI] [PubMed] [Google Scholar]
  5. Assanah M, Lochhead R, Ogden A, Bruce J, Goldman J, Canoll P. 2006. Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosci 26: 6781–6790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bansal R, Pfeiffer SE. 1997. FGF-2 converts mature oligodendrocytes to a novel phenotype. J Neurosci Res 50: 215–228. [DOI] [PubMed] [Google Scholar]
  7. Baracskay KL, Kidd GJ, Miller RH, Trapp BD. 2007. NG2-positive cells generate A2B5-positive oligodendrocyte precursor cells. Glia 55: 1001–1010. [DOI] [PubMed] [Google Scholar]
  8. Barnabé-Heider F, Göritz C, Sabelström H, Takebayashi H, Pfrieger FW, Meletis K, Frisén J. 2010. Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell 7: 470–482. [DOI] [PubMed] [Google Scholar]
  9. Baron W, Shattil SJ, ffrench-Constant C. 2002. The oligodendrocyte precursor mitogen PDGF stimulates proliferation by activation of αvβ3 integrins. EMBO J 21: 1957–1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Baron W, Colognato H, ffrench-Constant C. 2005. Integrin-growth factor interactions as regulators of oligodendroglial development and function. Glia 49: 467–479. [DOI] [PubMed] [Google Scholar]
  11. Barres BA, Raff MC. 1993. Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons. Nature 361: 258–260. [DOI] [PubMed] [Google Scholar]
  12. Barres BA, Koroshetz WJ, Swartz KJ, Chun LL, Corey DP. 1990. Ion channel expression by white matter glia: The O-2A glial progenitor cell. Neuron 4: 507–524. [DOI] [PubMed] [Google Scholar]
  13. Barres BA, Schmid R, Sendnter M, Raff MC. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118: 283–295. [DOI] [PubMed] [Google Scholar]
  14. Barres BA, Lazar MA, Raff MC. 1994. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120: 1097–1108. [DOI] [PubMed] [Google Scholar]
  15. Bellesi M, Pfister-Genskow M, Maret S, Keles S, Tononi G, Cirelli C. 2013. Effects of sleep and wake on oligodendrocytes and their precursors. J Neurosci 33: 14288–14300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bengtsson SL, Nagy Z, Skare S, Forsman L, Forssberg H, Ullén F. 2005. Extensive piano practicing has regionally specific effects on white matter development. Nat Neurosci 8: 1148–1150. [DOI] [PubMed] [Google Scholar]
  17. Bergles DE, ed. 2012. Physiology of NG2+ glial cells, 3rd ed. Oxford University Press, Oxford. [Google Scholar]
  18. Bergles DE, Roberts JD, Somogyi P, Jahr CE. 2000. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 405: 187–191. [DOI] [PubMed] [Google Scholar]
  19. Berry M, Hubbard P, Butt AM. 2002. Cytology and lineage of NG2-positive glia. J Neurocytol 31: 457–467. [DOI] [PubMed] [Google Scholar]
  20. Billon N, Terrinoni A, Jolicoeur C, McCarthy A, Richardson WD, Melino G, Raff M. 2004. Roles for p53 and p73 during oligodendrocyte development. Development 131: 1211–1220. [DOI] [PubMed] [Google Scholar]
  21. Bjartmar C, Hildebrand C, Loinder K. 1994. Morphological heterogeneity of rat oligodendrocytes: Electron microscopic studies on serial sections. Glia 11: 235–244. [DOI] [PubMed] [Google Scholar]
  22. Bögler O, Wren D, Barnett SC, Land H, Noble M. 1990. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci 87: 6368–6372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Boyd A, Zhang H, Williams A. 2013. Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol 125: 841–859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Brinkmann BG, Agarwal A, Sereda MW, Garratt AN, Müller T, Wende H, Stassart RM, Nawaz S, Humml C, Velanac V, et al. 2008. Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron 59: 581–595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Briscoe J, Ericson J. 2001. Specification of neuronal fates in the ventral neural tube. Curr Opin Neurobiol 11: 43–49. [DOI] [PubMed] [Google Scholar]
  26. Butt AM, Dinsdale J. 2005. Opposing actions of fibroblast growth factor-2 on early and late oligodendrocyte lineage cells in vivo. J Neuroimmunol 166: 75–87. [DOI] [PubMed] [Google Scholar]
  27. Butt AM, Ibrahim M, Berry M. 1998a. Axon-myelin sheath relations of oligodendrocyte unit phenotypes in the adult rat anterior medullary velum. J Neurocytol 27: 259–269. [PubMed] [Google Scholar]
  28. Butt AM, Ibrahim M, Gregson N, Berry M. 1998b. Differential expression of the L- and S-isoforms of myelin associated glycoprotein (MAG) in oligodendrocyte unit phenotypes in the adult rat anterior medullary velum. J Neurocytol 27: 271–280. [DOI] [PubMed] [Google Scholar]
  29. Butt AM, Kiff J, Hubbard P, Berry M. 2002. Synantocytes: New functions for novel NG2 expressing glia. J Neurocytol 31: 551–565. [DOI] [PubMed] [Google Scholar]
  30. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, et al. 2008. A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function. J Neurosci 28: 264–278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Cai J, Qi Y, Hu X, Tan M, Liu Z, Zhang J, Li Q, Sander M, Qiu M. 2005. Generation of oligodendrocyte precursor cells from mouse dorsal spinal cord independent of Nkx6 regulation and Shh signaling. Neuron 45: 41–53. [DOI] [PubMed] [Google Scholar]
  32. Calver AR, Hall AC, Yu WP, Walsh FS, Heath JK, Betsholtz C, Richardson WD. 1998. Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 20: 869–882. [DOI] [PubMed] [Google Scholar]
  33. Canoll PD, Musacchio JM, Hardy R, Reynolds R, Marchionni MA, Salzer JL. 1996. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 17: 229–243. [DOI] [PubMed] [Google Scholar]
  34. Cantarella C, Cayre M, Magalon K, Durbec P. 2008. Intranasal HB-EGF administration favors adult SVZ cell mobilization to demyelinated lesions in mouse corpus callosum. Dev Neurobiol 68: 223–236. [DOI] [PubMed] [Google Scholar]
  35. Carteron C, Ferrer-Montiel A, Cabedo H. 2006. Characterization of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival. J Cell Sci 119: 898–909. [DOI] [PubMed] [Google Scholar]
  36. Chandran S, Kato H, Gerreli D, Compston A, Svendsen CN, Allen ND. 2003. FGF-dependent generation of oligodendrocytes by a hedgehog-independent pathway. Development 130: 6599–6609. [DOI] [PubMed] [Google Scholar]
  37. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. 2000. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20: 6404–6412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Chittajallu R, Aguirre A, Gallo V. 2004. NG2-positive cells in the mouse white and grey matter display distinct physiological properties. J Physiol 561: 109–122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Chojnacki A, Weiss S. 2004. Isolation of a novel platelet-derived growth factor-responsive precursor from the embryonic ventral forebrain. J Neurosci 24: 10888–10899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Clarke LE, Young KM, Hamilton NB, Li H, Richardson WD, Attwell D. 2012. Properties and fate of oligodendrocyte progenitor cells in the corpus callosum, motor cortex, and piriform cortex of the mouse. J Neurosci 32: 8173–8185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Cohen RI, Marmur R, Norton WT, Mehler MF, Kessler JA. 1996. Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes. J Neurosci 16: 6433–6442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Coombs ID, Soto D, Zonouzi M, Renzi M, Shelley C, Farrant M, Cull-Candy SG. 2012. Cornichons modify channel properties of recombinant and glial AMPA receptors. J Neurosci 32: 9796–9804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Czopka T, ffrench-Constant C, Lyons DA. 2013. Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo. Dev Cell 25: 599–609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Dai ZM, Sun S, Wang C, Huang H, Hu X, Zhang Z, Lu QR, Qiu M. 2014. Stage-specific regulation of oligodendrocyte development by Wnt/β-catenin signaling. J Neurosci 34: 8467–8473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB. 2005. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8: 752–758. [DOI] [PubMed] [Google Scholar]
  46. Davies JE, Miller RH. 2001. Local Sonic hedgehog signaling regulates oligodendrocyte precursor appearance in multiple ventricular zone domains in the chick metencephalon. Dev Biol 233: 513–525. [DOI] [PubMed] [Google Scholar]
  47. Dawson MR, Polito A, Levine JM, Reynolds R. 2003. NG2-expressing glial progenitor cells: An abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci 24: 476–488. [DOI] [PubMed] [Google Scholar]
  48. De Biase LM, Nishiyama A, Bergles DE. 2010. Excitability and synaptic communication within the oligodendrocyte lineage. J Neurosci 30: 3600–3611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. De Biase LM, Kang SH, Baxi EG, Fukaya M, Pucak ML, Mishina M, Calabresi PA, Bergles DE. 2011. NMDA receptor signaling in oligodendrocyte progenitors is not required for oligodendrogenesis and myelination. J Neurosci 31: 12650–12662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. de Castro F, Bribian A. 2005. The molecular orchestra of the migration of oligodendrocyte precursors during development. Brain Res Brain Res Rev 49: 227–241. [DOI] [PubMed] [Google Scholar]
  51. Demerens C, Stankoff B, Logak M, Anglade P, Allinquant B, Couraud F, Zalc B, Lubetzki C. 1996. Induction of myelination in the central nervous system by electrical activity. Proc Natl Acad Sci 93: 9887–9892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. De Paola V, Holtmaat A, Knott G, Song S, Wilbrecht L, Caroni P, Svoboda K. 2006. Cell type-specific structural plasticity of axonal branches and boutons in the adult neocortex. Neuron 49: 861–875. [DOI] [PubMed] [Google Scholar]
  53. D’Ercole AJ, Ye P. 2008. Expanding the mind: Insulin-like growth factor I and brain development. Endocrinology 149: 5958–5962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Dimou L, Simon C, Kirchhoff F, Takebayashi H, Götz M. 2008. Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex. J Neurosci 28: 10434–10442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Dougherty JD, Fomchenko EI, Akuffo AA, Schmidt E, Helmy KY, Bazzoli E, Brennan CW, Holland EC, Milosevic A. 2012. Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma. Cancer Res 72: 4856–4868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Dugas JC, Ibrahim A, Barres BA. 2007. A crucial role for pp57(Kip2) in the intracellular timer that controls oligodendrocyte differentiation. J Neurosci 27: 6185–6196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Durand B, Raff M. 2000. A cell-intrinsic timer that operates during oligodendrocyte development. Bioessays 22: 64–71. [DOI] [PubMed] [Google Scholar]
  58. Durand B, Fero ML, Roberts JM, Raff MC. 1998. p27Kip1 alters the response of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation. Curr Biol 8: 431–440. [DOI] [PubMed] [Google Scholar]
  59. Dutta DJ, Zameer A, Mariani JN, Zhang J, Asp L, Huynh J, Mahase S, Laitman BM, Argaw AT, Mitiku N, et al. 2014. Combinatorial actions of Tgf-β and Activin ligands promote oligodendrocyte development and CNS myelination. Development 141: 2414–2428. [DOI] [PMC free article] [PubMed] [Google Scholar] [Research Misconduct Found]
  60. Dziembowska M, Tham TN, Lau P, Vitry S, Lazarini F, Dubois-Dalcq M. 2005. A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia 50: 258–269. [DOI] [PubMed] [Google Scholar]
  61. Ehninger D, Wang LP, Klempin F, Römer B, Kettenmann H, Kempermann G. 2011. Enriched environment and physical activity reduce microglia and influence the fate of NG2 cells in the amygdala of adult mice. Cell Tissue Res 345: 69–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. *.Emery B, Lu QR. 2015. Transcriptional and epigenetic regulation of oligodendrocyte development and myelination in the central nervous system. Cold Spring Harb Perspect Biol 10.1101/cshperspect.a020461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Fanarraga ML, Sommer I, Griffiths IR. 1995. O-2A progenitors of the mouse optic nerve exhibit a developmental pattern of antigen expression different from the rat. Glia 15: 95–104. [DOI] [PubMed] [Google Scholar]
  64. Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, Rowitch DH. 2009. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23: 1571–1585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Fernandez PA, Tang DG, Cheng L, Prochiantz A, Mudge AW, Raff MC. 2000. Evidence that axon-derived neuregulin promotes oligodendrocyte survival in the developing rat optic nerve. Neuron 28: 81–90. [DOI] [PubMed] [Google Scholar]
  66. Fields RD. 2008. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 31: 361–370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Fogarty M, Richardson WD, Kessaris N. 2005. A subset of oligodendrocytes generated from radial glia in the dorsal spinal cord. Development 132: 1951–1959. [DOI] [PubMed] [Google Scholar]
  68. Ford-Perriss M, Abud H, Murphy M. 2001. Fibroblast growth factors in the developing central nervous system. Clin Exp Pharmacol Physiol 28: 493–503. [DOI] [PubMed] [Google Scholar]
  69. Fortin D, Rom E, Sun H, Yayon A, Bansal R. 2005. Distinct fibroblast growth factor (FGF)/FGF receptor signaling pairs initiate diverse cellular responses in the oligodendrocyte lineage. J Neurosci 25: 7470–7479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. *.Franklin RJM, Goldman SA. 2015. Glia disease and repair—Remyelination. Cold Spring Harb Perspect Biol 10.1101/cshperspect.a020594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Fruttiger M, Karlsson L, Hall AC, Abramsson A, Calver AR, Bostrom H, Willetts K, Bertold CH, Heath JK, Betsholtz C, et al. 1999. Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 126: 457–467. [DOI] [PubMed] [Google Scholar]
  72. Fruttiger M, Calver AR, Richardson WD. 2000. Platelet-derived growth factor is constitutively secreted from neuronal cell bodies but not from axons. Curr Biol 10: 1283–1286. [DOI] [PubMed] [Google Scholar]
  73. Fu H, Cai J, Rutledge M, Hu X, Qiu M. 2003. Oligodendrocytes can be generated from the local ventricular and subventricular zones of embryonic chicken midbrain. Brain Res Dev Brain Res 143: 161–165. [DOI] [PubMed] [Google Scholar]
  74. Fu H, Cai J, Clevers H, Fast E, Gray S, Greenberg R, Jain MK, Ma Q, Qiu M, Rowitch DH, et al. 2009. A genome-wide screen for spatially restricted expression patterns identifies transcription factors that regulate glial development. J Neurosci 29: 11399–11408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Furusho M, Ono K, Takebayashi H, Masahira N, Kagawa T, Ikeda K, Ikenaka K. 2006. Involvement of the Olig2 transcription factor in cholinergic neuron development of the basal forebrain. Dev Biol 293: 348–357. [DOI] [PubMed] [Google Scholar]
  76. Furusho M, Kaga Y, Ishii A, Hebert JM, Bansal R. 2011. Fibroblast growth factor signaling is required for the generation of oligodendrocyte progenitors from the embryonic forebrain. J Neurosci 31: 5055–5066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Furusho M, Dupree JL, Nave KA, Bansal R. 2012. Fibroblast growth factor receptor signaling in oligodendrocytes regulates myelin sheath thickness. J Neurosci 32: 6631–6641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Gallo V, Zhou JM, McBain CJ, Wright P, Knutson PL, Armstrong RC. 1996. Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K+ channel block. J Neurosci 16: 2659–2670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Garcion E, Faissner A, ffrench-Constant C. 2001. Knockout mice reveal a contribution of the extracellular matrix molecule tenascin-C to neural precursor proliferation and migration. Development 128: 2485–2496. [DOI] [PubMed] [Google Scholar]
  80. Ge WP, Yang XJ, Zhang Z, Wang HK, Shen W, Deng QD, Duan S. 2006. Long-term potentiation of neuron-glia synapses mediated by Ca2+-permeable AMPA receptors. Science 312: 1533–1537. [DOI] [PubMed] [Google Scholar]
  81. Ge WP, Zhou W, Luo Q, Jan LY, Jan YN. 2009. Dividing glial cells maintain differentiated properties including complex morphology and functional synapses. Proc Natl Acad Sci 106: 328–333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Gibson EM, Purger D, Mount CW, Goldstein AK, Lin GL, Wood LS, Inema I, Miller SE, Bieri G, Zuchero JB, et al. 2014. Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science 344: 1252304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Gonzalez-Perez O, Alvarez-Buylla A. 2011. Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor. Brain Res Rev 67: 147–156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Göttle P, Kremer D, Jander S, Odemis V, Engele J, Hartung HP, Kury P. 2010. Activation of CXCR7 receptor promotes oligodendroglial cell maturation. Ann Neurol 68: 915–924. [DOI] [PubMed] [Google Scholar]
  85. Greenwood K, Butt AM. 2003. Evidence that perinatal and adult NG2-glia are not conventional oligodendrocyte progenitors and do not depend on axons for their survival. Mol Cell Neurosci 23: 544–558. [DOI] [PubMed] [Google Scholar]
  86. Gregg C, Shikar V, Larsen P, Mak G, Chojnacki A, Yong VW, Weiss S. 2007. White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci 27: 1812–1823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Gudz TI, Komuro H, Macklin WB. 2006. Glutamate stimulates oligodendrocyte progenitor migration mediated via an αv integrin/myelin proteolipid protein complex. J Neurosci 26: 2458–2466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Guo F, Ma J, McCauley E, Bannerman P, Pleasure D. 2009. Early postnatal proteolipid promoter-expressing progenitors produce multilineage cells in vivo. J Neurosci 29: 7256–7270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Guo F, Maeda Y, Ma J, Xu J, Horiuchi M, Miers L, Vaccarino F, Pleasure D. 2010. Pyramidal neurons are generated from oligodendroglial progenitor cells in adult piriform cortex. J Neurosci 30: 12036–12049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Guo F, Maeda Y, Ko EM, Delgado M, Horiuchi M, Soulika A, Miers L, Burns T, Itoh T, Shen H, et al. 2012. Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development. J Neurosci 32: 639–645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Haberlandt C, Derouiche A, Wyczynski A, Haseleu J, Pohle J, Karram K, Trotter J, Seifert G, Frotscher M, Steinhäuser C, et al. 2011. Gray matter NG2 cells display multiple Ca2+-signaling pathways and highly motile processes. PLoS ONE 6: e17575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Hajihosseini M, Tham TN, Dubois-Dalcq M. 1996. Origin of oligodendrocytes within the human spinal cord. J Neurosci 16: 7981–7994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Hall A, Giese NA, Richardson WD. 1996. Spinal cord oligodendrocytes develop from ventrally derived progenitor cells that express PDGF α-receptors. Development 122: 4085–4094. [DOI] [PubMed] [Google Scholar]
  94. Hamada T, Ui-Tei K, Imaki J, Takahashi F, Onodera H, Mishima T, Miyata Y. 2002. The expression of SCDGF/PDGF-C/fallotein and SCDGF-B/PDGF-D in the rat central nervous system. Mech Dev 112: 161–164. [DOI] [PubMed] [Google Scholar]
  95. Hart IK, Richardson WD, Bolsover SR, Raff MC. 1989. PDGF and intracellular signaling in the timing of oligodendrocyte differentiation. J Cell Biol 109: 3411–3417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. He W, Ingraham C, Rising L, Goderie S, Temple S. 2001. Multipotent stem cells from the mouse basal forebrain contribute GABAergic neurons and oligodendrocytes to the cerebral cortex during embryogenesis. J Neurosci 21: 8854–8862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Hill RA, Patel KD, Medved J, Reiss AM, Nishiyama A. 2013. NG2 cells in white matter but not gray matter proliferate in response to PDGF. J Neurosci 33: 14558–14566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Hu QD, Ang BT, Karsak M, Hu WP, Cui XY, Duka T, Takeda Y, Chia W, Sankar N, Ng YK, et al. 2003. F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell 115: 163–175. [DOI] [PubMed] [Google Scholar]
  99. Hughes EG, Kang SH, Fukaya M, Bergles DE. 2013. Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain. Nat Neurosci 16: 668–676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Iannarelli P. 2014. “Oligodendrocyte population dynamics and plasticity probed by genetic manipulation in mice.” PhD thesis, University College London, London. [Google Scholar]
  101. Ibarrola N, Mayer-Proschel M, Rodriguez-Pena A, Noble M. 1996. Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro. Dev Biol 180: 1–21. [DOI] [PubMed] [Google Scholar]
  102. Ivanova A, Nakahira E, Kagawa T, Oba A, Wada T, Takebayashi H, Spassky N, Levine J, Zalc B, Ikenaka K. 2003. Evidence for a second wave of oligodendrogenesis in the postnatal cerebral cortex of the mouse. J Neurosci Res 73: 581–592. [DOI] [PubMed] [Google Scholar]
  103. Jablonska B, Aguirre A, Raymond M, Szabo G, Kitabatake Y, Sailor KA, Ming GL, Song H, Gallo V. 2010. Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination. Nat Neurosci 13: 541–550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Jabs R, Kirchhoff F, Kettenmann H, Steinhäuser C. 1994. Kainate activates Ca2+-permeable glutamate receptors and blocks voltage-gated K+ currents in glial cells of mouse hippocampal slices. Pflugers Arch 426: 310–319. [DOI] [PubMed] [Google Scholar]
  105. Jabs R, Pivneva T, Huttmann K, Wyczynski A, Nolte C, Kettenmann H, Steinhäuser C. 2005. Synaptic transmission onto hippocampal glial cells with hGFAP promoter activity. J Cell Sci 118: 3791–3803. [DOI] [PubMed] [Google Scholar]
  106. Jarjour AA, Manitt C, Moore SW, Thompson KM, Yuh SJ, Kennedy TE. 2003. Netrin-1 is a chemorepellent for oligodendrocyte precursor cells in the embryonic spinal cord. J Neurosci 23: 3735–3744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Kang SH, Fukaya M, Yang JK, Rothstein JD, Bergles DE. 2010. NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron 68: 668–681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Káradóttir R, Cavelier P, Bergersen LH, Attwell D. 2005. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438: 1162–1166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Káradóttir R, Hamilton NB, Bakiri Y, Attwell D. 2008. Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter. Nat Neurosci 11: 450–456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Kay JN, Chu MW, Sanes JR. 2012. MEGF10 and MEGF11 mediate homotypic interactions required for mosaic spacing of retinal neurons. Nature 483: 465–469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Kessaris N, Jamen F, Rubin LL, Richardson WD. 2004. Cooperation between sonic Hedgehog and fibroblast growth factor/MAPK signalling pathways in neocortical precursors. Development 131: 1289–1298. [DOI] [PubMed] [Google Scholar]
  112. Kessaris N, Fogarty M, Iannarelli P, Grist M, Wegner M, Richardson WD. 2006. Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nat Neurosci 9: 173–179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Kim H, Shin J, Kim S, Poling J, Park HC, Appel B. 2008. Notch-regulated oligodendrocyte specification from radial glia in the spinal cord of zebrafish embryos. Dev Dyn 237: 2081–2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Kimura F, Itami C. 2009. Myelination and isochronicity in neural networks. Front Neuroanat 3: 12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Kleopa KA, Orthmann JL, Enriquez A, Paul DL, Scherer SS. 2004. Unique distributions of the gap junction proteins connexin29, connexin32, and connexin47 in oligodendrocytes. Glia 47: 346–357. [DOI] [PubMed] [Google Scholar]
  116. Komitova M, Serwanski DR, Lu QR, Nishiyama A. 2011. NG2 cells are not a major source of reactive astrocytes after neocortical stab wound injury. Glia 59: 800–809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Kukley M, Capetillo-Zarate E, Dietrich D. 2007. Vesicular glutamate release from axons in white matter. Nat Neurosci 10: 311–320. [DOI] [PubMed] [Google Scholar]
  118. Kukley M, Kiladze M, Tognatta R, Hans M, Swandulla D, Schramm J, Dietrich D. 2008. Glial cells are born with synapses. FASEB J 22: 2957–2969. [DOI] [PubMed] [Google Scholar]
  119. Kukley M, Nishiyama A, Dietrich D. 2010. The fate of synaptic input to NG2 glial cells: Neurons specifically downregulate transmitter release onto differentiating oligodendroglial cells. J Neurosci 30: 8320–8331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Langseth AJ, Munji RN, Choe Y, Huynh T, Pozniak CD, Pleasure SJ. 2010. Wnts influence the timing and efficiency of oligodendrocyte precursor cell generation in the telencephalon. J Neurosci 30: 13367–13372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Lasiene J, Matsui A, Sawa Y, Wong F, Horner PJ. 2009. Age-related myelin dynamics revealed by increased oligodendrogenesis and short internodes. Aging Cell 8: 201–213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Levison SW, Goldman JE. 1993. Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron 10: 201–212. [DOI] [PubMed] [Google Scholar]
  123. Li H, Richardson WD. 2008. The evolution of Olig genes and their roles in myelination. Neuron Glia Biol 4: 129–135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Li Q, Brus-Ramer M, Martin JH, McDonald JW. 2010. Electrical stimulation of the medullary pyramid promotes proliferation and differentiation of oligodendrocyte progenitor cells in the corticospinal tract of the adult rat. Neurosci Lett 479: 128–133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Li H, Paes de Faria JP, Andrew P, Nitarska J, Richardson WD. 2011. Phosphorylation regulates OLIG2 cofactor choice and the motor neuron-oligodendrocyte fate switch. Neuron 69: 918–929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Lin SC, Bergles DE. 2004. Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus. Nat Neurosci 7: 24–32. [DOI] [PubMed] [Google Scholar]
  127. Lin SC, Huck JH, Roberts JD, Macklin WB, Somogyi P, Bergles DE. 2005. Climbing fiber innervation of NG2-expressing glia in the mammalian cerebellum. Neuron 46: 773–785. [DOI] [PubMed] [Google Scholar]
  128. Lindberg N, Kastemar M, Olofsson T, Smits A, Uhrbom L. 2009. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene 28: 2266–2275. [DOI] [PubMed] [Google Scholar]
  129. Liu C, Sage JC, Miller MR, Verhaak RG, Hippenmeyer S, Vogel H, Foreman O, Bronson RT, Nishiyama A, Luo L, et al. 2011. Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 146: 209–221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Liu J, Dietz K, DeLoyht JM, Pedre X, Kelkar D, Kaur J, Vialou V, Lobo MK, Dietz DM, Nestler EJ, et al. 2012. Impaired adult myelination in the prefrontal cortex of socially isolated mice. Nat Neurosci 15: 1621–1623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH. 2002. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109: 75–86. [DOI] [PubMed] [Google Scholar]
  132. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. 1999. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122: 2279–2295. [DOI] [PubMed] [Google Scholar]
  133. Makinodan M, Rosen KM, Ito S, Corfas G. 2012. A critical period for social experience-dependent oligodendrocyte maturation and myelination. Science 337: 1357–1360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Mangin JM, Kunze A, Chittajallu R, Gallo V. 2008. Satellite NG2 progenitor cells share common glutamatergic inputs with associated interneurons in the mouse dentate gyrus. J Neurosci 28: 7610–7623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Matsumoto Y, Tsunekawa Y, Nomura T, Suto F, Matsumata M, Tsuchiya S, Osumi N. 2011. Differential proliferation rhythm of neural progenitor and oligodendrocyte precursor cells in the young adult hippocampus. PLoS ONE 6: e27628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. McCarthy GF, Leblond CP. 1988. Radioautographic evidence for slow astrocyte turnover and modest oligodendrocyte production in the corpus callosum of adult mice infused with 3H-thymidine. J Comp Neurol 271: 589–603. [DOI] [PubMed] [Google Scholar]
  137. McKenzie IO, Ohayon D, Paes de Faria J, Li H, Emery B, Tohyama K, Richardson WD. 2014. Motor skills learning requires active central myelination. Science 346: 318–322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA. 1990. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5: 603–614. [DOI] [PubMed] [Google Scholar]
  139. McMorris FA, Smith TM, DeSalvo S, Furlanetto RW. 1986. Insulin-like growth factor I/somatomedin C: A potent inducer of oligodendrocyte development. Proc Natl Acad Sci 83: 822–826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Mekki-Dauriac S, Agius E, Kan P, Cochard P. 2002. Bone morphogenetic proteins negatively control oligodendrocyte precursor specification in the chick spinal cord. Development 129: 5117–5130. [DOI] [PubMed] [Google Scholar]
  141. Miller RH, Dinsio K, Wang R, Geertman R, Maier CE, Hall AK. 2004. Patterning of spinal cord oligodendrocyte development by dorsally derived BMP4. J Neurosci Res 76: 9–19. [DOI] [PubMed] [Google Scholar]
  142. Mora A. 2005. “Studies of gliogenesis in the central nervous system of zebrafish (Danio rerio).” PhD thesis, University of London. [Google Scholar]
  143. Muller J, Reyes-Haro D, Pivneva T, Nolte C, Schaette R, Lubke J, Kettenmann H. 2009. The principal neurons of the medial nucleus of the trapezoid body and NG2+ glial cells receive coordinated excitatory synaptic input. J Gen Physiol 134: 115–127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Murtie JC, Zhou YX, Le TQ, Armstrong RC. 2005. In vivo analysis of oligodendrocyte lineage development in postnatal FGF2 null mice. Glia 49: 542–554. [DOI] [PubMed] [Google Scholar]
  145. Nakahira E, Kagawa T, Shimizu T, Goulding MD, Ikenaka K. 2006. Direct evidence that ventral forebrain cells migrate to the cortex and contribute to the generation of cortical myelinating oligodendrocytes. Dev Biol 291: 123–131. [DOI] [PubMed] [Google Scholar]
  146. Nazarenko I, Hedrén A, Sjödin H, Orrego A, Afink GG, Nistér M, Lindström MS. 2011. Brain abnormalities and glioma-like lesions in mice overexpressing the long isoform of PDGF-A in astrocytic cells. PLoS ONE 6: e18303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Nery S, Wichterle H, Fishell G. 2001. Sonic hedgehog contributes to oligodendrocyte specification in the mammalian forebrain. Development 128: 527–540. [DOI] [PubMed] [Google Scholar]
  148. Nimmerjahn A, Kirchhoff F, Helmchen F. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314–1318. [DOI] [PubMed] [Google Scholar]
  149. Nishiyama A, Lin XH, Giese N, Heldin CH, Stallcup WB. 1996. Interaction between NG2 proteoglycan and PDGF α-receptor on O2A progenitor cells is required for optimal response to PDGF. J Neurosci Res 43: 315–330. [DOI] [PubMed] [Google Scholar]
  150. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P. 1988. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333: 560–562. [DOI] [PubMed] [Google Scholar]
  151. Noll E, Miller RH. 1994. Regulation of oligodendrocyte differentiation: A role for retinoic acid in the spinal cord. Development 120: 649–660. [DOI] [PubMed] [Google Scholar]
  152. Olivier C, Cobos I, Perez Villegas EM, Spassky N, Zalc B, Martinez S, Thomas JL. 2001. Monofocal origin of telencephalic oligodendrocytes in the anterior entopeduncular area of the chick embryo. Development 128: 1757–1769. [DOI] [PubMed] [Google Scholar]
  153. Ono K, Bansal R, Payne J, Rutishauser U, Miller RH. 1995. Early development and dispersal of oligodendrocyte precursors in the embryonic chick spinal cord. Development 121: 1743–1754. [DOI] [PubMed] [Google Scholar]
  154. Ono K, Yasui Y, Rutishauser U, Miller RH. 1997. Focal ventricular origin and migration of oligodendrocyte precursors into the chick optic nerve. Neuron 19: 283–292. [DOI] [PubMed] [Google Scholar]
  155. Orentas DM, Miller RH. 1996. The origin of spinal cord oligodendrocytes is dependent on local influences from the notochord. Dev Biol 177: 43–53. [DOI] [PubMed] [Google Scholar]
  156. Ortega MC, Bribian A, Peregrin S, Gil MT, Marin O, de Castro F. 2012. Neuregulin-1/ErbB4 signaling controls the migration of oligodendrocyte precursor cells during development. Exp Neurol 235: 610–620. [DOI] [PubMed] [Google Scholar]
  157. Paes de Faria J, Kessaris N, Andrew P, Richardson WD, Li H. 2014. New Olig1 null mice confirm a non-essential role for Olig1 in oligodendrocyte development. BMC Neurosci 15: 12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Palazuelos J, Klingener M, Aguirre A. 2014. TGF-β signaling regulates the timing of CNS myelination by modulating oligodendrocyte progenitor cell cycle exit through SMAD3/4/FoxO1/Sp1. J Neurosci 34: 7917–7930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Park HC, Appel B. 2003. Delta-Notch signaling regulates oligodendrocyte specification. Development 130: 3747–3755. [DOI] [PubMed] [Google Scholar]
  160. Park HC, Mehta A, Richardson JS, Appel B. 2002. olig2 is required for zebrafish primary motor neuron and oligodendrocyte development. Dev Biol 248: 356–368. [DOI] [PubMed] [Google Scholar]
  161. Patneau DK, Wright PW, Winters C, Mayer ML, Gallo V. 1994. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron 12: 357–371. [DOI] [PubMed] [Google Scholar]
  162. Persson AI, Petritsch C, Swartling FJ, Itsara M, Sim FJ, Auvergne R, Goldenberg DD, Vandenberg SR, Nguyen KN, Yakovenko S, et al. 2010. Non-stem cell origin for oligodendroglioma. Cancer Cell 18: 669–682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Peters A, Kemper T. 2012. A review of the structural alterations in the cerebral hemispheres of the aging rhesus monkey. Neurobiol Aging 33: 2357–2372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Petryniak MA, Potter GB, Rowitch DH, Rubenstein JL. 2007. Dlx1 and Dlx2 control neuronal versus oligodendroglial cell fate acquisition in the developing forebrain. Neuron 55: 417–433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Poncet C, Soula C, Trousse F, Kan P, Hirsinger E, Pourquie O, Duprat AM, Cochard P. 1996. Induction of oligodendrocyte progenitors in the trunk neural tube by ventralizing signals: Effects of notochord and floor plate grafts, and of Sonic hedgehog. Mech Dev 60: 13–32. [DOI] [PubMed] [Google Scholar]
  166. Pringle NP, Richardson WD. 1993. A singularity of PDGF α-receptor expression in the dorsoventral axis of the neural tube may define the origin of the oligodendrocyte lineage. Development 117: 525–533. [DOI] [PubMed] [Google Scholar]
  167. Pringle NP, Mudhar HS, Collarini EJ, Richardson WD. 1992. PDGF receptors in the rat CNS: During late neurogenesis, PDGF α-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage. Development 115: 535–551. [DOI] [PubMed] [Google Scholar]
  168. Pringle NP, Yu WP, Guthrie S, Roelink H, Lumsden A, Peterson AC, Richardson WD. 1996. Determination of neuroepithelial cell fate: Induction of the oligodendrocyte lineage by ventral midline cells and Sonic hedgehog. Dev Biol 177: 30–42. [DOI] [PubMed] [Google Scholar]
  169. Pringle NP, Yu WP, Howell M, Colvin JS, Ornitz DM, Richardson WD. 2003. Fgfr3 expression by astrocytes and their precursors: Evidence that astrocytes and oligodendrocytes originate in distinct neuroepithelial domains. Development 130: 93–102. [DOI] [PubMed] [Google Scholar]
  170. Psachoulia K, Jamen F, Young KM, Richardson WD. 2009. Cell cycle dynamics of NG2 cells in the postnatal and ageing brain. Neuron Glia Biol 5: 57–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Rabadan MA, Cayuso J, Le Dreau G, Cruz C, Barzi M, Pons S, Briscoe J, Marti E. 2012. Jagged2 controls the generation of motor neuron and oligodendrocyte progenitors in the ventral spinal cord. Cell Death Differ 19: 209–219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Raff MC, Miller RH, Noble M. 1983. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303: 390–396. [DOI] [PubMed] [Google Scholar]
  173. Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD. 1988. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333: 562–565. [DOI] [PubMed] [Google Scholar]
  174. Reigstad LJ, Varhaug JE, Lillehaug JR. 2005. Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. FEBS J 272: 5723–5741. [DOI] [PubMed] [Google Scholar]
  175. Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M. 1988. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53: 309–319. [DOI] [PubMed] [Google Scholar]
  176. Richardson WD, Pringle NP, Yu WP, Hall AC. 1997. Origins of spinal cord oligodendrocytes: Possible developmental and evolutionary relationships with motor neurons. Dev Neurosci 19: 58–68. [DOI] [PubMed] [Google Scholar]
  177. Richardson WD, Kessaris N, Pringle N. 2006. Oligodendrocyte wars. Nat Rev Neurosci 7: 11–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Richardson WD, Young KM, Tripathi RB, McKenzie I. 2011. NG2-glia as multipotent neural stem cells: Fact or fantasy? Neuron 70: 661–673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Rivers LE, Young KM, Rizzi M, Jamen F, Psachoulia K, Wade A, Kessaris N, Richardson WD. 2008. PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat Neurosci 11: 1392–1401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Robins SC, Trudel E, Rotondi O, Liu X, Djogo T, Kryzskaya D, Bourque CW, Kokoeva MV. 2013. Evidence for NG2-glia derived, adult-born functional neurons in the hypothalamus. PLoS ONE 8: e78236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Robinson S, Tani M, Strieter RM, Ransohoff RM, Miller RH. 1998. The chemokine growth-regulated oncogene-α promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci 18: 10457–10463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Rodriguez-Pena A. 1999. Oligodendrocyte development and thyroid hormone. J Neurobiol 40: 497–512. [DOI] [PubMed] [Google Scholar]
  183. Sampaio-Baptista C, Khrapitchev AA, Foxley S, Schlagheck T, Scholz J, Jbabdi S, DeLuca GC, Miller KL, Taylor A, Thomas N, et al. 2013. Motor skill learning induces changes in white matter microstructure and myelination. J Neurosci 33: 19499–19503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Sandell JH, Peters A. 2002. Effects of age on the glial cells in the rhesus monkey optic nerve. J Comp Neurol 445: 13–28. [DOI] [PubMed] [Google Scholar]
  185. Scafidi J, Hammond TR, Scafidi S, Ritter J, Jablonska B, Roncal M, Szigeti-Buck K, Coman D, Huang Y, McCarter RJ Jr, et al. 2014. Intranasal epidermal growth factor treatment rescues neonatal brain injury. Nature 506: 230–234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Scholz J, Klein MC, Behrens TE, Johansen-Berg H. 2009. Training induces changes in white-matter architecture. Nat Neurosci 12: 1370–1371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. See JM, Grinspan JB. 2009. Sending mixed signals: Bone morphogenetic protein in myelination and demyelination. J Neuropathol Exp Neurol 68: 595–604. [DOI] [PubMed] [Google Scholar]
  188. Seidl AH, Rubel EW, Barria A. 2014. Differential conduction velocity regulation in ipsilateral and contralateral collaterals innervating brainstem coincidence detector neurons. J Neurosci 34: 4914–4919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Seifert G, Rehn L, Weber M, Steinhauser C. 1997. AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. Brain Res Mol Brain Res 47: 286–294. [DOI] [PubMed] [Google Scholar]
  190. Shimizu T, Kagawa T, Wada T, Muroyama Y, Takada S, Ikenaka K. 2005. Wnt signaling controls the timing of oligodendrocyte development in the spinal cord. Dev Biol 282: 397–410. [DOI] [PubMed] [Google Scholar]
  191. Silvestroff L, Franco PG, Pasquini JM. 2013. Neural and oligodendrocyte progenitor cells: Transferrin effects on cell proliferation. ASN Neuro 5: e00107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Simon C, Götz M, Dimou L. 2011. Progenitors in the adult cerebral cortex: Cell cycle properties and regulation by physiological stimuli and injury. Glia 59: 869–881. [DOI] [PubMed] [Google Scholar]
  193. Spassky N, de Castro F, Le Bras B, Heydon K, Quéraud-LeSaux F, Bloch-Gallego E, Chédotal A, Zalc B, Thomas JL. 2002. Directional guidance of oligodendroglial migration by class 3 semaphorins and netrin-1. J Neurosci 22: 5992–6004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  194. Stecca B, Ruiz IAA. 2010. Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. J Mol Cell Biol 2: 84–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Steinhäuser C, Jabs R, Kettenmann H. 1994. Properties of GABA and glutamate responses in identified glial cells of the mouse hippocampal slice. Hippocampus 4: 19–35. [DOI] [PubMed] [Google Scholar]
  196. Sugawa M, Sakurai Y, Ishikawa-Ieda Y, Suzuki H, Asou H. 2002. Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci Res 44: 391–403. [DOI] [PubMed] [Google Scholar]
  197. Sugimoto Y, Taniguchi M, Yagi T, Akagi Y, Nojyo Y, Tamamaki N. 2001. Guidance of glial precursor cell migration by secreted cues in the developing optic nerve. Development 128: 3321–3330. [DOI] [PubMed] [Google Scholar]
  198. Sun Y, Goderie SK, Temple S. 2005. Asymmetric distribution of EGFR receptor during mitosis generates diverse CNS progenitor cells. Neuron 45: 873–886. [DOI] [PubMed] [Google Scholar]
  199. Syed YA, Hand E, Möbius W, Zhao C, Hofer M, Nave KA, Kotter MR. 2011. Inhibition of CNS remyelination by the presence of semaphorin 3A. J Neurosci 31: 3719–3728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Takebayashi H, Nabeshima Y, Yoshida S, Chisaka O, Ikenaka K. 2002. The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr Biol 12: 1157–1163. [DOI] [PubMed] [Google Scholar]
  201. Tanaka Y, Tozuka Y, Takata T, Shimazu N, Matsumura N, Ohta A, Hisatsune T. 2009. Excitatory GABAergic activation of cortical dividing glial cells. Cereb Cortex 19: 2181–2195. [DOI] [PubMed] [Google Scholar]
  202. Tang DG, Tokumoto YM, Raff MC. 2000. Long-term culture of purified postnatal oligodendrocyte precursor cells. Evidence for an intrinsic maturation program that plays out over months. J Cell Biol 148: 971–984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Tatsumi K, Takebayashi H, Manabe T, Tanaka KF, Makinodan M, Yamauchi T, Makinodan E, Matsuyoshi H, Okuda H, Ikenaka K, et al. 2008. Genetic fate mapping of Olig2 progenitors in the injured adult cerebral cortex reveals preferential differentiation into astrocytes. J Neurosci Res 86: 3494–3502. [DOI] [PubMed] [Google Scholar]
  204. Taveggia C, Thaker P, Petrylak A, Caporaso GL, Toews A, Falls DL, Einheber S, Salzer JL. 2008. Type III neuregulin-1 promotes oligodendrocyte myelination. Glia 56: 284–293. [DOI] [PubMed] [Google Scholar]
  205. Tekki-Kessaris N, Woodruff R, Hall AC, Gaffield W, Kimura S, Stiles CD, Rowitch DH, Richardson WD. 2001. Hedgehog-dependent oligodendrocyte lineage specification in the telencephalon. Development 128: 2545–2554. [DOI] [PubMed] [Google Scholar]
  206. Temple S, Raff MC. 1985. Differentiation of a bipotential glial progenitor cell in a single cell microculture. Nature 313: 223–225. [DOI] [PubMed] [Google Scholar]
  207. Temple S, Raff MC. 1986. Clonal analysis of oligodendrocyte development in culture: Evidence for a developmental clock that counts cell divisions. Cell 44: 773–779. [DOI] [PubMed] [Google Scholar]
  208. Timsit S, Martinez S, Allinquant B, Peyron F, Puelles L, Zalc B. 1995. Oligodendrocytes originate in a restricted zone of the embryonic ventral neural tube defined by DM-20 mRNA expression. J Neurosci 15: 1012–1024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Tokumoto YM, Tang DG, Raff MC. 2001. Two molecularly distinct intracellular pathways to oligodendrocyte differentiation: Role of a p53 family protein. EMBO J 20: 5261–5268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  210. Tripathi RB, Rivers LE, Young KM, Jamen F, Richardson WD. 2010. NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease. J Neurosci 30: 16383–16390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  211. Tripathi RB, Clarke LE, Burzomato V, Kessaris N, Anderson PN, Attwell D, Richardson WD. 2011. Dorsally and ventrally derived oligodendrocytes have similar electrical properties but myelinate preferred tracts. J Neurosci 31: 6809–6819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Tsai HH, Tessier-Lavigne M, Miller RH. 2003. Netrin 1 mediates spinal cord oligodendrocyte precursor dispersal. Development 130: 2095–2105. [DOI] [PubMed] [Google Scholar]
  213. Tsoa RW, Coskun V, Ho CK, de Vellis J, Sun YE. 2014. Spatiotemporally different origins of NG2 progenitors produce cortical interneurons versus glia in the mammalian forebrain. Proc Natl Acad Sci 111: 7444–7449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Vallstedt A, Klos JM, Ericson J. 2005. Multiple dorsoventral origins of oligodendrocyte generation in the spinal cord and hindbrain. Neuron 45: 55–67. [DOI] [PubMed] [Google Scholar]
  215. van Heyningen P, Calver AR, Richardson WD. 2001. Control of progenitor cell number by mitogen supply and demand. Curr Biol 11: 232–241. [DOI] [PubMed] [Google Scholar]
  216. Vartanian T, Fischbach G, Miller R. 1999. Failure of spinal cord oligodendrocyte development in mice lacking neuregulin. Proc Natl Acad Sci 96: 731–735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Velez-Fort M, Maldonado PP, Butt AM, Audinat E, Angulo MC. 2010. Postnatal switch from synaptic to extrasynaptic transmission between interneurons and NG2 cells. J Neurosci 30: 6921–6929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Vondran MW, Clinton-Luke P, Honeywell JZ, Dreyfus CF. 2010. BDNF+/− mice exhibit deficits in oligodendrocyte lineage cells of the basal forebrain. Glia 58: 848–856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Wake H, Lee PR, Fields RD. 2011. Control of local protein synthesis and initial events in myelination by action potentials. Science 333: 1647–1651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Walters SN, Morell P. 1981. Effects of altered thyroid states on myelinogenesis. J Neurochem 36: 1792–1801. [DOI] [PubMed] [Google Scholar]
  221. Wang S, Young KM. 2014. White matter plasticity in adulthood. Neuroscience 276C: 148–160. [DOI] [PubMed] [Google Scholar]
  222. Wang S, Sdrulla AD, diSibio G, Bush G, Nofziger D, Hicks C, Weinmaster G, Barres BA. 1998. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21: 63–75. [DOI] [PubMed] [Google Scholar]
  223. Watkins TA, Emery B, Mulinyawe S, Barres BA. 2008. Distinct stages of myelination regulated by γ-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron 60: 555–569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  224. Wong AW, Xiao J, Kemper D, Kilpatrick TJ, Murray SS. 2013. Oligodendroglial expression of TrkB independently regulates myelination and progenitor cell proliferation. Nat Neurosci 33: 4947–4957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. Woodruff RF, Fruttiger M, Richardson WD, Franklin RJM. 2004. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci 25: 252–262. [DOI] [PubMed] [Google Scholar]
  226. Wyllie DJ, Mathie A, Symonds CJ, Cull-Candy SG. 1991. Activation of glutamate receptors and glutamate uptake in identified macroglial cells in rat cerebellar cultures. J Physiol 432: 235–258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Xin M, Yue T, Ma Z, Wu FF, Gow A, Lu QR. 2005. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J Neurosci 25: 1354–1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  228. Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, Hu T, Taketo MM, van Es JH, Clevers H, et al. 2009. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin-TCF interaction. Nat Neurosci 12: 829–838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. Young KM, Mitsumori T, Pringle N, Grist M, Kessaris N, Richardson WD. 2010. An Fgfr3-iCreERT2 transgenic mouse line for studies of neural stem cells and astrocytes. Glia 58: 943–953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  230. Young KM, Psachoulia K, Tripathi RB, Dunn SJ, Cossell L, Attwell D, Tohyama K, Richardson WD. 2013. Oligodendrocyte dynamics in the healthy adult CNS: Evidence for myelin remodeling. Neuron 77: 873–885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. Yuan X, Eisen AM, McBain CJ, Gallo V. 1998. A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices. Development 125: 2901–2914. [DOI] [PubMed] [Google Scholar]
  232. Yung SY, Gokhan S, Jurcsak J, Molero AE, Abrajano JJ, Mehler MF. 2002. Differential modulation of BMP signaling promotes the elaboration of cerebral cortical GABAergic neurons or oligodendrocytes from a common Sonic hedgehog–responsive ventral forebrain progenitor species. Proc Natl Acad Sci 99: 16273–16278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Zatorre RJ, Fields RD, Johansen-Berg H. 2012. Plasticity in gray and white: Neuroimaging changes in brain structure during learning. Nat Neurosci 15: 528–536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  234. Zaucker A, Mercurio S, Sternheim N, Talbot WS, Marlow FL. 2013. notch3 is essential for oligodendrocyte development and vascular integrity in zebrafish. Dis Model Mech 6: 1246–1259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  235. Zawadzka M, Rivers LE, Fancy SP, Zhao C, Tripathi R, Jamen F, Young K, Goncharevich A, Pohl H, Rizzi M, et al. 2010. CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 6: 578–590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  236. Zerlin M, Milosevic A, Goldman JE. 2004. Glial progenitors of the neonatal subventricular zone differentiate asynchronously, leading to spatial dispersion of glial clones and to the persistence of immature glia in the adult mammalian CNS. Dev Biol 270: 200–213. [DOI] [PubMed] [Google Scholar]
  237. Zhang H, Miller RH. 1995. Asynchronous differentiation of clonally related spinal cord oligodendrocytes. Mol Cell Neurosci 6: 16–31. [DOI] [PubMed] [Google Scholar]
  238. Zhao YY, Shi XY, Qiu X, Lu W, Yang S, Li C, Chen L, Zhang L, Cheng GH, Tang Y. 2012. Enriched environment increases the myelinated nerve fibers of aged rat corpus callosum. Anat Rec (Hoboken) 295: 999–1005. [DOI] [PubMed] [Google Scholar]
  239. Zhou Q, Anderson DJ. 2002. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109: 61–73. [DOI] [PubMed] [Google Scholar]
  240. Zhu Q, Whittemore SR, Devries WH, Zhao X, Kuypers NJ, Qiu M. 2011a. Dorsally-derived oligodendrocytes in the spinal cord contribute to axonal myelination during development and remyelination following focal demyelination. Glia 59: 1612–1621. [DOI] [PubMed] [Google Scholar]
  241. Zhu X, Hill RA, Dietrich D, Komitova M, Suzuki R, Nishiyama A. 2011b. Age-dependent fate and lineage restriction of single NG2 cells. Development 138: 745–753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  242. Zhu X, Zuo H, Maher BJ, Serwanski DR, LoTurco JJ, Lu QR, Nishiyama A. 2012. Olig2-dependent developmental fate switch of NG2 cells. Development 139: 2299–2307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  243. Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles DE. 2007. Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci 10: 321–330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Zonouzi M, Renzi M, Farrant M, Cull-Candy SG. 2011. Bidirectional plasticity of calcium-permeable AMPA receptors in oligodendrocyte lineage cells. Nat Neurosci 14: 1430–1438. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cold Spring Harbor Perspectives in Biology are provided here courtesy of Cold Spring Harbor Laboratory Press

RESOURCES